{"study_id": 183093, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether vitamin K supplementation reduced vascular stiffness or calcification in kidney transplant recipients.", "results_summary": "The study found no significant impact of vitamin K on vascular stiffness or calcification in kidney transplant recipients over 1 year of treatment. The treatment effect was minimal and not statistically significant.", "population_specificity": "Kidney transplant recipients (KTRs)", "effective_dosage": "Menadiol diphosphate 5 mg thrice weekly", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:26.970676+00:00"}
{"study_id": 183095, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the measurement, standardization, and clinical interpretation of vitamin D metabolites and their binding protein, particularly in relation to calcium and phosphate homeostasis.", "results_summary": "The study highlights the importance of accurate measurement of vitamin D metabolites, particularly 25(OH)D, for assessing vitamin D status and its role in bone metabolism. It also discusses the need for standardization of these measurements to improve clinical guidelines and supplementation strategies.", "population_specificity": "General discussion on clinical practice and bone metabolism, no specific population mentioned.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:29.461954+00:00"}
{"study_id": 183096, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether high volume hemofiltration (HVHF) with calcium supplementation could stabilize severe HCPS patients and reduce the need for VA ECMO.", "results_summary": "HVHF with calcium supplementation was used in severe HCPS patients, with some avoiding VA ECMO; targeted-HVHF strategies showed potential for improving outcomes.", "population_specificity": "Severe HCPS patients requiring mechanical ventilation and vasoactive drugs in an intensive care unit.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:30.062697+00:00"}
{"study_id": 183098, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare parathyroid recovery rates between children and adults with persistent hypoparathyroidism after total thyroidectomy and identify predictive factors for recovery.", "results_summary": "Nearly half of patients recovered from persistent hypoparathyroidism after 6 months, with similar recovery rates in children and adults. A PGRIS score of 4 and serum calcium >2.25 mmol/L at 1 month were predictive of recovery.", "population_specificity": "Patients (children and adults) with persistent hypoparathyroidism after total thyroidectomy.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 20 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:30.837085+00:00"}
{"study_id": 183097, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to investigate the link between persistent hypomagnesemia induced by tacrolimus and calcium pyrophosphate deposition (CPPD) in a liver transplant patient.", "results_summary": "The study found that hypomagnesemia caused by tacrolimus led to CPPD, presenting as acute oligoarthritis and low back pain. After switching to everolimus and supplementing magnesium, the patient's symptoms resolved without relapse over 8 months.", "population_specificity": "A 53-year-old male liver transplant recipient.", "effective_dosage": "Not specified", "study_duration": "8 months follow-up", "interactions": "Tacrolimus (renal magnesium loss), proton pump inhibitor (potential contributor to hypomagnesemia)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:31.398922+00:00"}
{"study_id": 183100, "supplement_id": 969, "safety_score": "20", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to investigate the potential harm of calcium supplementation during SARS-CoV-2 infection, particularly its effects on the cardio-renal system due to hyperactive calcium-sensing receptors (CaSR).", "results_summary": "The study suggests that calcium supplementation during SARS-CoV-2 infection may exacerbate cardio-renal damage by increasing intracellular calcium, oxidative stress, and inflammatory stress. Pharmacological inhibition of CaSR was proposed as a potential intervention to mitigate these effects.", "population_specificity": "Subjects infected with SARS-CoV-2 exhibiting high cytokine levels and coagulation activation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:33.316868+00:00"}
{"study_id": 183099, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether vitamin D supplementation improves muscle strength in postmenopausal persons living with HIV (PLWH).", "results_summary": "Vitamin D supplementation modestly increased lower extremity strength in postmenopausal PLWH without increasing muscle mass. Both 1,000 IU and 3,000 IU daily doses showed similar strength improvements.", "population_specificity": "African American and Hispanic postmenopausal PLWH on antiretroviral therapy with 25-OHD levels between 10-32 ng/ml.", "effective_dosage": "1,000 IU daily (low dose) and 3,000 IU daily (moderate dose).", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:33.486299+00:00"}
{"study_id": 183101, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of oxidative stress and increased cytoplasmic calcium in neuronal dysfunction in Alzheimer's disease (AD) and evaluate potential nutraceutical interventions to mitigate these effects.", "results_summary": "The study suggests that oxidative stress and elevated cytoplasmic calcium contribute to neuronal damage in AD, and a nutraceutical regimen including antioxidants, DHA, and vitamin D may help counteract amyloid \u03b2 toxicity and reduce AD risk.", "population_specificity": "Elderly individuals at risk for Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:34.121656+00:00"}
{"study_id": 183102, "supplement_id": 969, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the safety and efficacy of an oral hPTH(1-34) formulation as an adjunct to standard calcium and calcitriol treatment in adults with hypoparathyroidism.", "results_summary": "The study found that oral hPTH(1-34) reduced exogenous calcium supplementation by 42%, maintained normocalcemia, and decreased serum phosphate levels by 23%. A non-significant 21% reduction in urinary calcium excretion and a small but significant 5% improvement in quality of life were also observed.", "population_specificity": "Adult subjects with hypoparathyroidism (19 enrolled, 15 completed).", "effective_dosage": "0.75 mg oral hPTH(1-34) acetate tablets administered four times daily.", "study_duration": "16 consecutive weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:37.852233+00:00"}
{"study_id": 183103, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine how patient-provider relationship continuity influenced adherence to osteoporosis care guidelines, including daily calcium intake.", "results_summary": "Relationship continuity (PCP ordering the DXA) was associated with higher average daily calcium intake and increased likelihood of vitamin D supplementation at 52 weeks. No PCP or clinic factors were linked to osteoporosis care.", "population_specificity": "Men and women aged \u226550 years who completed a DXA scan and had baseline and 52-week follow-up data.", "effective_dosage": "Not specified", "study_duration": "52 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:37.853567+00:00"}
{"study_id": 183105, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers reviewed basic and clinical studies to evaluate the neuroprotective effects of magnesium (a natural calcium antagonist) in treating cerebral ischemia.", "results_summary": "The abstract does not directly discuss Calcium's effects but focuses on magnesium's mixed results in treating cerebral ischemia, with basic studies showing promise but clinical trials failing to improve patient prognosis.", "population_specificity": "Patients with cerebral ischemia (ischemic stroke).", "effective_dosage": "Not specified for Calcium.", "study_duration": "Not specified for Calcium.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:39.145224+00:00"}
{"study_id": 183106, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the anti-inflammatory effects of vitamin D supplementation (cholecalciferol) under uremic conditions and its impact on mineral metabolism parameters in hemodialysis patients.", "results_summary": "Cholecalciferol supplementation improved vitamin D levels and reduced iPTH but did not significantly affect mineral metabolism or inflammatory markers (IL-1\u03b2, hs-CRP) in patients. In vitro, it counteracted uremic serum-induced monocyte dysfunction.", "population_specificity": "Hemodialysis patients (N=32)", "effective_dosage": "Cholecalciferol (150 nM in vitro; dosage for patients not specified)", "study_duration": "Six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:40.272411+00:00"}
{"study_id": 183104, "supplement_id": 969, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether pre- and postoperative calcium and calcitriol supplementation reduces postoperative hypocalcemia after total thyroidectomy compared with postoperative supplementation alone.", "results_summary": "The study found no significant difference in hypocalcemia rates between the intervention (pre- and postoperative supplementation) and control (postoperative supplementation alone) groups. Secondary outcomes, including postoperative calcium levels, need for intervention, length of stay, and readmissions, also showed no significant differences.", "population_specificity": "Patients undergoing total thyroidectomy (excluded partial thyroidectomy or concurrent planned parathyroidectomy).", "effective_dosage": "Calcitriol 0.25 \u03bcg orally twice daily and calcium carbonate 1,500 mg orally three times daily.", "study_duration": "5 days preoperatively and continued postoperatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:41.337175+00:00"}
{"study_id": 183110, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of maternal calcium supplementation on reducing risks of adverse pregnancy outcomes related to placental disorders and maternal mortality.", "results_summary": "The study found that calcium supplementation, particularly in combination with vitamin D, was effective in reducing risks of adverse maternal and fetal health outcomes, though the evidence quality was noted as poor.", "population_specificity": "Pregnant women at risk of placental disorders or adverse pregnancy outcomes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:41.559611+00:00"}
{"study_id": 183109, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether energy reduction combined with calcium supplementation could help prevent type 2 diabetes mellitus (T2DM) in overweight individuals.", "results_summary": "The study found that energy-reduction groups (ERGs) showed lower \u0394BMI values compared to non-energy-reduction groups (NERGs), suggesting a potential benefit of dietary energy reduction. However, the abstract does not provide specific results on calcium supplementation's standalone or combined effects.", "population_specificity": "Overweight individuals (n=1021)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:42.247096+00:00"}
{"study_id": 183108, "supplement_id": 969, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a single high dose of vitamin D3 (which influences calcium metabolism) could reduce hospital length of stay in COVID-19 patients.", "results_summary": "The study found no significant difference in hospital length of stay, mortality, ICU admission, or need for mechanical ventilation between the vitamin D3 and placebo groups. Serum 25-hydroxyvitamin D levels increased significantly in the treatment group, but this did not translate to clinical benefits.", "population_specificity": "Hospitalized patients with moderate to severe COVID-19 in Brazil.", "effective_dosage": "Single oral dose of 200,000 IU vitamin D3.", "study_duration": "Single dose, with follow-up until hospital discharge or death.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:42.757388+00:00"}
{"study_id": 183112, "supplement_id": 969, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the roles of calcium, magnesium, and strontium in musculoskeletal and cardiovascular health, focusing on clinical evidence and safety profiles.", "results_summary": "Calcium supplementation is most effective for bone health when combined with vitamin D or antiosteoporosis medications, with gastrointestinal side effects and a slight risk of renal stones noted. No convincing evidence links calcium supplementation to adverse cardiovascular outcomes.", "population_specificity": "Individuals with potential calcium deficiency or osteoporosis, particularly those without cardiovascular risk factors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:45.837181+00:00"}
{"study_id": 183113, "supplement_id": 969, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether soy protein supplementation, which includes calcium, affects body weight, blood pressure, and various biochemical markers in middle-aged to older men at risk of cancer recurrence.", "results_summary": "Soy supplementation did not affect serum calcium levels compared to casein, indicating no significant impact on calcium metabolism. Other parameters like body weight, blood pressure, and thyroid hormones also remained unchanged.", "population_specificity": "Middle-aged to older men (44-75 years) at risk of cancer recurrence following prostatectomy.", "effective_dosage": "20 g/d soy protein isolate (calcium content not specified).", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:46.616007+00:00"}
{"study_id": 183114, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the common nutritional challenges and solutions, including Calcium, in orthopedic patients and astronauts.", "results_summary": "The study found that both orthopedic patients and astronauts face similar nutritional issues, including musculoskeletal involution, and benefit from tailored diets with nutrients like Calcium. The review highlights the potential for shared nutritional strategies between these two fields.", "population_specificity": "Orthopedic patients (primarily elderly) and astronauts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:47.193702+00:00"}
{"study_id": 183117, "supplement_id": 969, "safety_score": "60", "efficacy_score": 40, "quality_score": 80, "study_goal": "The researchers aimed to determine whether calcium supplements are helpful, harmful, or neutral for cardiovascular health.", "results_summary": "Some observational and RCT studies suggested potential cardiovascular harm from calcium supplementation, while others did not. The authors recommend cautious use of calcium supplements, favoring dietary sources.", "population_specificity": "Not specified (general population inferred).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:48.819610+00:00"}
{"study_id": 183118, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of calcium supplementation on cardiovascular disease outcomes and all-cause mortality.", "results_summary": "The study found no effect of calcium supplementation on cardiovascular disease outcomes or all-cause mortality, consistent with previous findings. No preventive benefits were demonstrated.", "population_specificity": "General population (not specified further in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:49.300015+00:00"}
{"study_id": 183115, "supplement_id": 969, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of a calcium-fortified nutritional supplement on bone metabolism in young Indian women.", "results_summary": "The study found favorable changes in bone turnover markers (e.g., decreased serum CTX and PINP) and calcium homeostasis, suggesting potential slowing of bone loss. Improvements in vitamin K status and B vitamins were also noted, though their direct impact on fracture risk remains uncertain.", "population_specificity": "Young Indian women aged 25 to 44.", "effective_dosage": "600 mg calcium, 400 IU vitamin D, and 55 mcg vitamin K per daily serving.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:49.310177+00:00"}
{"study_id": 183116, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a single high dose of oral cholecalciferol (vitamin D3) improves respiratory outcomes in COVID-19 patients at moderate risk of complications compared to placebo.", "results_summary": "The abstract does not provide results on the effects of cholecalciferol, as the study is ongoing and only describes the trial design and protocol.", "population_specificity": "Adults (\u226545 years or with specific comorbidities) hospitalized with confirmed COVID-19 and moderate risk of complications in Argentina.", "effective_dosage": "Single oral dose of 500,000 IU cholecalciferol (5 capsules of 100,000 IU).", "study_duration": "Single-dose intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:50.574333+00:00"}
{"study_id": 183121, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether vitamin D or calcium supplementation reduces all-cause mortality and cardiovascular outcomes.", "results_summary": "The study found no meaningful associations between calcium supplementation (alone or combined with vitamin D) and all-cause mortality, cardiovascular mortality, myocardial infarction, or other major adverse cardiovascular events (MACEs).", "population_specificity": "Community-dwelling adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:53.897186+00:00"}
{"study_id": 183120, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness and cost-effectiveness of calcium-fortified foods on calcium intake and related health or economic outcomes.", "results_summary": "Calcium intake increased significantly in intervention groups, with the most marked effects seen in children, including improved height, reduced plasma parathyroid hormone, and increased bone mineral density.", "population_specificity": "Women and children aged 1 to 72 months, primarily from low-income settings.", "effective_dosage": "Fortification levels between 96 and 1200 mg per 100 g of food.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:54.743554+00:00"}
{"study_id": 183122, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how gut bacterial metabolism of 5-HTP to 5-HI affects gut motility via L-type calcium channels in colonic smooth muscle cells.", "results_summary": "The study found that 5-HI, derived from bacterial metabolism of 5-HTP, accelerates gut transit time by activating L-type calcium channels and increases serotonin production in intestinal enterochromaffin cells.", "population_specificity": "Healthy volunteers (fecal samples) and rats (in vivo studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:55.922947+00:00"}
{"study_id": 183124, "supplement_id": 969, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of vitamin D replacement in patients with primary hyperparathyroidism (PHPT) and vitamin D deficiency.", "results_summary": "Vitamin D supplementation significantly reduced PTH and ALP levels without causing hypercalcemia or hypercalciuria. Serum calcium and 24-h urinary calcium levels remained unchanged, indicating no adverse effects on calcium metabolism.", "population_specificity": "Patients with primary hyperparathyroidism (PHPT) and vitamin D deficiency (total of 388 patients across 11 studies).", "effective_dosage": "Not specified", "study_duration": "Intervention time varied, with subgroup analysis focusing on effects beyond 1 month.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:58.045679+00:00"}
{"study_id": 183126, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of Klotho in calcium-phosphate homeostasis and its implications in aging-related diseases, including hypertension.", "results_summary": "The study highlights Klotho's role in regulating calcium-phosphate homeostasis, with Klotho deficiency linked to accelerated aging and cardiovascular injury, while supplementation may slow disease progression.", "population_specificity": "General discussion of aging-related diseases (hypertension, cardiovascular, and chronic kidney disease) and mouse models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:58.441872+00:00"}
{"study_id": 183123, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if postoperative serum calcium and parathyroid hormone measurements and oral calcium/calcitriol supplementation could be omitted in patients with at least one well-perfused parathyroid gland identified by intra-operative ICG angiography.", "results_summary": "The study found no statistically significant differences in serum calcium and parathyroid hormone levels between patients who received oral supplementation and those who did not, suggesting that supplementation may be unnecessary when a well-perfused parathyroid gland is confirmed.", "population_specificity": "Patients undergoing surgery with at least one well-perfused parathyroid gland (ICG score >2).", "effective_dosage": "Not specified (systematic supplementation in control group).", "study_duration": "Measurements taken on the first and 30th postoperative day.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:12:59.256231+00:00"}
{"study_id": 183125, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of different doses of vitamin D supplementation on 25(OH)D levels and related biochemical markers (including calcium) in children with excess weight.", "results_summary": "The study found that higher doses of vitamin D (1000 and 2000 IU) increased 25(OH)D levels more effectively than 600 IU, but no significant changes were observed in serum calcium, phosphorus, or alkaline phosphatase levels across groups.", "population_specificity": "Children and adolescents aged 6-13 years with a BMI Z-score \u2265 1 (excess weight).", "effective_dosage": "600, 1000, and 2000 IU of vitamin D per day.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:00.038968+00:00"}
{"study_id": 183127, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to estimate the prevalence of vitamin D deficiency in thalassemia patients and its association with osteoporosis/low bone mass.", "results_summary": "The prevalence of vitamin D deficiency varied widely among thalassemia patients, with only three out of five studies showing a statistically significant positive association between vitamin D levels and bone mineral density (BMD). The evidence was insufficient to conclude whether vitamin D supplementation improves BMD in this population.", "population_specificity": "Patients with thalassemia, a chronic congenital disease.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:02.337557+00:00"}
{"study_id": 183128, "supplement_id": 969, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of calcium and vitamin D supplements on bone density and fracture risk, focusing on human studies.", "results_summary": "Calcium and vitamin D supplements, when combined, reduce fracture risk, especially in populations with low intakes. The safety of these interventions at recommended intakes is supported by extensive analyses.", "population_specificity": "Populations with low calcium and vitamin D intakes, particularly during aging.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:02.535680+00:00"}
{"study_id": 183119, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of a phototherapy kiosk versus oral vitamin D3 supplementation in increasing serum 25(OH)D levels.", "results_summary": "The phototherapy kiosk group achieved higher median serum 25(OH)D levels (30 ng/mL) compared to the oral supplement group (26 ng/mL) at 10 weeks, with the difference persisting at 14 weeks. Both groups had similar baseline levels, but the phototherapy group maintained higher levels over time.", "population_specificity": "Mostly female (60%), median age 35 years, with low daily intake of calcium and vitamin D.", "effective_dosage": "Not specified for calcium; vitamin D3 dosage not detailed.", "study_duration": "10 weeks of intervention, with follow-up at 14 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:03.707518+00:00"}
{"study_id": 183129, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to examine the effects of calcium and vitamin D supplementation in a patient with skeletal fluorosis exacerbated by calcium deficiency.", "results_summary": "The study found that calcium and vitamin D supplementation improved the condition of a patient with recurrent long bone fractures and hypocalcemia, suggesting potential benefits in addressing calcium deficiency-related complications.", "population_specificity": "A 51-year-old man with chronic musculoskeletal pain, hypocalcemia, secondary hyperparathyroidism, and a history of poor dietary calcium intake.", "effective_dosage": "Not specified", "study_duration": "5 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:05.442529+00:00"}
{"study_id": 183130, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of vitamin D in calcium and phosphorus homeostasis and its potential extra-skeletal effects, particularly in the cardiovascular system.", "results_summary": "The study found that vitamin D deficiency is linked to cardiovascular risk factors and higher CVD incidence, but randomized controlled trials did not confirm benefits of supplementation for CVD prevention. Vitamin D's role in calcium homeostasis was reaffirmed, but its extra-skeletal effects remain inconclusive.", "population_specificity": "Individuals with vitamin D deficiency (serum 25-hydroxyvitamin D < 20 ng/dl).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:07.583041+00:00"}
{"study_id": 183131, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Vitamin D supplementation, with or without calcium, could prevent Alzheimer's disease.", "results_summary": "The study found no significant difference in cognitive outcomes between the Vitamin D intervention group (with or without calcium) and the comparison group. High heterogeneity was observed, and baseline Vitamin D levels or follow-up duration did not explain the variability.", "population_specificity": "2345 participants across nine randomized clinical trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:07.727987+00:00"}
{"study_id": 183132, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of vitamin D in pulmonary inflammatory diseases and its potential therapeutic effects on inflammatory cells.", "results_summary": "The study found strong correlations between vitamin D deficiency and the progression of lung disorders, with vitamin D showing inhibitory effects on pulmonary inflammation and enhancing innate immune defenses. However, the underlying mechanisms remain unclear, and further research is needed.", "population_specificity": "Not specified (general focus on pulmonary diseases like asthma, COPD, pneumonia, etc.)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:08.278449+00:00"}
{"study_id": 183133, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of vitamin D supplementation on rickets risk and linear growth in young stunted children, with consideration of dietary calcium intake.", "results_summary": "Vitamin D supplementation showed no significant effect on rickets prevalence or growth, except in children with higher calcium intake. Mean dietary calcium intake was insufficient at 372 mg/day.", "population_specificity": "3046 children aged 1 to 11 months from inner-city Kabul, Afghanistan.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:09.363978+00:00"}
{"study_id": 183135, "supplement_id": 969, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine the association between calcium intake (dietary and supplemental) and cardiovascular disease incidence and mortality.", "results_summary": "Moderate dietary calcium intake was associated with reduced all-cause and cardiovascular mortality, as well as fewer incident strokes. Calcium supplementation was linked to reduced mortality in women but not men.", "population_specificity": "17,968 participants aged 40-79 years from the EPIC-Norfolk study.", "effective_dosage": "Quintiles of calcium intake: <770 mg/day, 771-926 mg/day, 1074-1254 mg/day.", "study_duration": "Median follow-up of 20.36 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:13.019528+00:00"}
{"study_id": 183136, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the role of calcium deficiency in nutritional rickets and osteomalacia, and evaluate treatment and prevention strategies involving calcium and vitamin D.", "results_summary": "The study found that calcium deficiency is a leading cause of nutritional rickets, particularly in tropical and malnourished populations, and that adequate calcium intake through diet or supplementation is essential for treatment and prevention. Combined with vitamin D, calcium effectively addresses mineralization defects and prevents life-threatening complications.", "population_specificity": "High-risk groups including children, infants, pregnant and lactating women, and malnourished populations in tropical and high-latitude countries.", "effective_dosage": "Not specified (only mentions \"adequate calcium intake\").", "study_duration": "Lifelong maintenance supplementation recommended after initial high-dose vitamin D treatment (minimum 12 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:14.558048+00:00"}
{"study_id": 183139, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the efficacy of non-pharmacological interventions, including calcium supplementation, on musculoskeletal measures in osteosarcopenic adults.", "results_summary": "The study did not assess the effects of calcium supplementation, as no eligible RCTs examined its impact against a control/placebo in this population.", "population_specificity": "Older osteosarcopenic adults (\u226565 years)", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:15.532747+00:00"}
{"study_id": 183137, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of vitamin D-calcium supplementation on metabolic profile and oxidative stress in women with gestational diabetes mellitus (GDM) controlled by diet.", "results_summary": "Higher-dose supplementation (1000 IU vitamin D + 1000 mg calcium) significantly improved glucose metabolism, lipid profiles, and oxidative stress markers compared to lower-dose supplementation (250 IU vitamin D + 500 mg calcium). Both doses showed a significant effect on oxidative stress (total glutathione levels).", "population_specificity": "Women diagnosed with GDM at 24-28 weeks of gestation, controlled on a diabetic diet.", "effective_dosage": "Group A: 1000 IU vitamin D + 1000 mg calcium daily; Group B: 250 IU vitamin D + 500 mg calcium daily.", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:15.959280+00:00"}
{"study_id": 183140, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of calcium in improving bone health in children and adolescents post-solid organ transplantation.", "results_summary": "The study highlights that adequate calcium intake, alongside other nutrients, is crucial for bone health in transplant recipients. It suggests that calcium supplementation, combined with vitamin D and reduced glucocorticoid use, can improve bone outcomes.", "population_specificity": "Children and adolescents who have undergone solid organ transplantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Glucocorticoids and immunosuppressive agents may adversely affect bone function, while calcium and vitamin D supplementation can mitigate these effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:17.446138+00:00"}
{"study_id": 183141, "supplement_id": 969, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of an algorithm-based RCA protocol for maintaining serum calcium stability during renal replacement therapy.", "results_summary": "The algorithm-based RCA protocol maintained serum calcium stability without additional adjustments, while the trial-and-error protocol resulted in hypocalcemia and required frequent calcium supplementation. No participants showed unsafe post-filter calcium levels.", "population_specificity": "Critically ill patients undergoing renal replacement therapy.", "effective_dosage": "Not specified (algorithm-based dosing).", "study_duration": "18 hemofiltration treatments (duration per treatment not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:18.695100+00:00"}
{"study_id": 183134, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the importance of adequate calcium and phosphorus intake for preventing osteopenia of prematurity in preterm infants.", "results_summary": "The study found that adequate parenteral and enteral calcium and phosphorus intakes are crucial for preventing osteopenia of prematurity, and screening serum phosphate concentrations is useful.", "population_specificity": "Preterm infants, particularly very preterm and extremely preterm infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:18.907544+00:00"}
{"study_id": 183138, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effect of high-dose versus standard-dose cholecalciferol (vitamin D) on all-cause 14-day mortality in older adults with COVID-19 at higher risk of worsening.", "results_summary": "The abstract does not provide specific results regarding Calcium's effects, as the study primarily focuses on vitamin D supplementation and its impact on COVID-19 outcomes.", "population_specificity": "Older adults aged \u226565 years with COVID-19 and at least one worsening risk factor (age \u226575 years, SpO2 \u226494%, or PaO2/FiO2 \u2264300 mmHg).", "effective_dosage": "High-dose cholecalciferol (400,000 IU once) and standard-dose cholecalciferol (50,000 IU once).", "study_duration": "Single dose administered on the day of inclusion, with follow-up for 28 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:18.950431+00:00"}
{"study_id": 183142, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of leucine metabolite supplements on phase angle, bioimpedance vector analysis patterns, and strength during resistance training.", "results_summary": "The abstract does not provide results specific to Calcium.", "population_specificity": "Fifty-three male participants.", "effective_dosage": "Not specified.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:21.358914+00:00"}
{"study_id": 183143, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to describe an unusual case of sporadic pseudohypoparathyroidism type 1B and evaluate the effectiveness of combined calcium, vitamin D, and magnesium supplementation in managing the condition.", "results_summary": "The study found that combined calcium, vitamin D, and magnesium supplementation improved symptoms and biochemical markers in a patient with pseudohypoparathyroidism type 1B, though mild intermittent paresthesias persisted. Symptomatic remission was achieved after treatment readjustment and one year of follow-up.", "population_specificity": "A 34-year-old Caucasian woman with sporadic pseudohypoparathyroidism type 1B.", "effective_dosage": "Not specified", "study_duration": "One year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:24.533357+00:00"}
{"study_id": 183146, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether low-dose calcium supplementation reduces blood pressure in non-pregnant women with a history of pre-eclampsia.", "results_summary": "Low-dose calcium supplementation significantly reduced systolic and mean arterial pressure in non-pregnant women with previous pre-eclampsia, particularly in those with severe features, though no significant interaction was found between severity and treatment effect.", "population_specificity": "Non-pregnant women with a history of pre-eclampsia or eclampsia.", "effective_dosage": "500 mg/day elemental calcium", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:25.658034+00:00"}
{"study_id": 183148, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the physiological effects of palm oil/olein (PO/POL) in infant formulas, including its impact on calcium absorption and bone mineralization.", "results_summary": "The study found that PO/POL in infant formulas leads to lower calcium absorption and reduced bone mineralization compared to formulas without PO/POL.", "population_specificity": "Healthy infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:26.339001+00:00"}
{"study_id": 183145, "supplement_id": 969, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of oral vitamin D supplementation on linear growth and other health outcomes in infants and children under five years of age, focusing on calcium homeostasis and skeletal health.", "results_summary": "Vitamin D supplementation showed little to no significant difference in linear growth, stunting, hypercalciuria, or hypercalcaemia compared to placebo or lower doses, but may slightly improve length/height-for-age z-score (L/HAZ).", "population_specificity": "Infants and children under five years of age, primarily from India, USA, and Canada.", "effective_dosage": "Doses ranged from 200 to 6000 IU daily or up to 600,000 IU bolus at enrolment.", "study_duration": "Varied across studies; not explicitly stated in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:26.686913+00:00"}
{"study_id": 183150, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the preventive effect of calcium supplementation, alone or combined with vitamin D, on musculoskeletal injuries in armed forces.", "results_summary": "The study found some evidence supporting the preventive effect of calcium supplementation, alone or combined with vitamin D, on musculoskeletal injuries, though the overall quality of evidence was very low.", "population_specificity": "Armed forces personnel", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:27.034735+00:00"}
{"study_id": 183144, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between serum magnesium (SMg) concentration and cardiovascular morbidity, mortality, and kidney failure progression in CKD patients, with indirect implications for calcium due to its interactions with magnesium.", "results_summary": "Calcium supplements were associated with lower serum magnesium (SMg) concentration, but no direct effects of calcium on outcomes were reported. Hypermagnesemia, influenced by factors like calcitriol and calcium supplements, was linked to higher cardiovascular events and all-cause mortality.", "population_specificity": "746 patients with chronic kidney disease (CKD), mean age 70 \u00b1 13 years, 62.9% male, predominantly CKD grades 3 and 4.", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 42.6 months", "interactions": "Calcium supplements and proton pump inhibitors (PPIs) were associated with lower SMg concentration; calcitriol use was linked to higher SMg.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:27.561346+00:00"}
{"study_id": 183151, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combined calcium and vitamin D supplementation benefits osteoporosis in postmenopausal women.", "results_summary": "Combined calcium and vitamin D significantly increased bone mineral density (BMD) in multiple areas (total, lumbar spine, arms, femoral neck) and reduced hip fracture incidence. Subgroup analysis showed femoral neck BMD improvement only with vitamin D doses \u2264400 IU/day.", "population_specificity": "Postmenopausal women with osteoporosis.", "effective_dosage": "Vitamin D dose \u2264400 IU/day (specific calcium dosage not mentioned).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:30.054587+00:00"}
{"study_id": 183147, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the predictive value of total, bioavailable, and free 25(OH)D on bone and mineral metabolism indices in response to two vitamin D doses, with calcium supplementation.", "results_summary": "Higher vitamin D doses led to 1.3-1.4-fold higher levels of all vitamin D variables. Total 25(OH)D correlated with femoral neck BMD changes, while free and bioavailable 25(OH)D correlated with total body BMD changes, but none were superior to total 25(OH)D in predicting bone health.", "population_specificity": "Overweight individuals >65 years with baseline serum 25(OH)D levels of 10-30 ng/mL.", "effective_dosage": "Calcium and oral vitamin D3 (600 IU/day or 3750 IU/day).", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:30.303376+00:00"}
{"study_id": 183152, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between vitamin D status and pediatric bone health, as well as potential broader health benefits.", "results_summary": "Observational studies suggest vitamin D levels of 50 nmol/L prevent rickets and 75 nmol/L optimize health, but randomized trials show equivocal results. Supplementation of 10-50 \u03bcg/day appears safe and may benefit pediatric health beyond bone outcomes.", "population_specificity": "Children (toddlers, children, and adolescents)", "effective_dosage": "10-50 \u03bcg/day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:33.039317+00:00"}
{"study_id": 183153, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether supplemental calcium (alone or with vitamin D) could influence gut barrier function and potentially prevent colorectal carcinogenesis.", "results_summary": "The study tested supplemental calcium (1,200 mg/day) and/or vitamin D but did not provide specific results regarding calcium's effects in the abstract. Further details would be needed to assess outcomes.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "1,200 mg/day", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:34.280470+00:00"}
{"study_id": 183154, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of maternal vitamin D supplementation during pregnancy on maternal and neonatal cord blood levels of toxic metals (lead, cadmium, manganese, and mercury).", "results_summary": "Vitamin D supplementation did not affect maternal cadmium, mercury, or manganese levels but was associated with nonsignificant increases in maternal lead and significant increases in cord blood lead and cadmium. These increases were not dose-dependent.", "population_specificity": "Pregnant women in Dhaka, Bangladesh, during their second trimester.", "effective_dosage": "Weekly doses of 4,200, 16,800, or 28,000 IU of vitamin D3.", "study_duration": "From the second trimester of pregnancy until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:35.662908+00:00"}
{"study_id": 183157, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of calcium supplementation (500 mg elemental calcium) on body weight in women before and during pregnancy.", "results_summary": "Women receiving calcium supplementation had a smaller mean weight increase (1.1 kg) compared to placebo (1.5 kg), but the difference was not statistically significant. The findings were consistent with previous studies but lacked conclusive evidence of efficacy.", "population_specificity": "Women recruited before pregnancy and followed until 20 weeks' gestation.", "effective_dosage": "500 mg elemental calcium daily until 20 weeks' gestation, then 1.5 g until delivery.", "study_duration": "From pre-pregnancy until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:36.227592+00:00"}
{"study_id": 183156, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to verify the roles of calcium, in combination with vitamin D, in the incidence and prognosis of lung cancer.", "results_summary": "The study found that while separate intake of calcium did not show a significant protective effect on lung cancer, the combination of vitamin D and calcium significantly decreased the incidence of lung cancer. High circulating 25(OH)D levels were associated with reduced lung cancer risk and mortality.", "population_specificity": "58,625 lung cancer cases from 40 studies (general population, not further specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:36.561893+00:00"}
{"study_id": 183155, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the effect of calcium supplement intake on lipid profile in randomized controlled clinical trials (RCTs).", "results_summary": "Calcium supplement intake was associated with a significant reduction in LDL-C levels, especially with higher doses (\u22651000 mg/day), longer durations (\u226512 weeks), and in individuals without dyslipidemia. However, lower doses (<1000 mg/day) increased Total Cholesterol (TC) levels, while no significant effects were observed for other blood lipids or subgroups.", "population_specificity": "Individuals in randomized controlled clinical trials, particularly those without dyslipidemia.", "effective_dosage": "\u22651000 mg/day and <1000 mg/day", "study_duration": "\u226512 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:36.631712+00:00"}
{"study_id": 183158, "supplement_id": 969, "safety_score": "40", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of odanacatib (ODN) as a treatment for osteoporosis in men, focusing on its effects on bone mineral density and bone resorption markers.", "results_summary": "ODN significantly improved bone mineral density at multiple sites and reduced bone resorption markers, with minimal reduction in bone formation markers. However, development was discontinued due to an increased risk of stroke observed in another study.", "population_specificity": "Men with idiopathic osteoporosis or osteoporosis due to hypogonadism, mean age 68.8 years.", "effective_dosage": "50 mg once weekly.", "study_duration": "24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:38.658690+00:00"}
{"study_id": 183159, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if vitamin D supplementation could modulate muscle cell damage caused by eccentric exercise in young men, focusing on its interaction with calcium and phosphate levels.", "results_summary": "The study found that vitamin D supplementation tailored to individual needs reduced muscle cell damage from eccentric exercise, with no indicated plasma calcium or phosphate disorders. Lower myoglobin concentrations post-exercise were observed in groups with initially suboptimal vitamin D levels.", "population_specificity": "60 male volunteers aged 20-24 years, divided into groups with suboptimal and optimal 25(OH)D plasma levels.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:39.089058+00:00"}
{"study_id": 183160, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to analyze the prevalence of calcium deficiencies in Eastern and Southern Africa and assess maize's role in addressing these deficiencies.", "results_summary": "The study found that maize provides very low calcium supply, contributing to high calcium deficiency rates (up to 66%) in these regions. Strategies like fortification and dietary diversification improved calcium intake but were not specifically detailed for calcium outcomes.", "population_specificity": "Women and children in Eastern and Southern Africa, particularly those with high maize consumption.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:41.188027+00:00"}
{"study_id": 183161, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the change in serum 25-hydroxyvitamin D levels, safety, and clinical impact of two vitamin D supplementation regimens in children with sickle cell disease.", "results_summary": "The abstract does not provide specific results regarding Calcium's effects, only mentioning the comparison of two vitamin D supplementation regimens.", "population_specificity": "Children (5-17 years) with sickle cell disease (all genotypes).", "effective_dosage": "Not specified (mentions a single bolus of vitamin D).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:42.645728+00:00"}
{"study_id": 183162, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the adequacy of calcium intake in toddler diets and its absorption using stable isotope techniques.", "results_summary": "The study found that calcium intakes in most toddlers in the USA are adequate when diets include milk or mineral-fortified alternatives, suggesting no widespread deficiency. Stable isotope methods were used to assess absorption, but specific efficacy outcomes for calcium supplementation were not detailed.", "population_specificity": "Toddlers (young children in early childhood)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:43.895142+00:00"}
{"study_id": 183165, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the relationship between vitamin D (involved in calcium metabolism) and the pathophysiological processes of PCOS, including metabolic and reproductive outcomes.", "results_summary": "Vitamin D levels were negatively associated with serum androgen levels and IR parameters. Supplementation improved menstrual cycles, folliculogenesis, and lipid metabolism in PCOS patients.", "population_specificity": "Reproductive-age women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:44.045172+00:00"}
{"study_id": 183163, "supplement_id": 969, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to provide an evidence-based overview of emergency department management strategies for calcium channel blocker overdose, beta blocker overdose, and digoxin toxicity.", "results_summary": "The study highlights the complexity of managing acute overdoses versus chronic toxicity, emphasizing the need for tailored treatment strategies in bradycardic and hypotensive patients. It focuses on the caveats of treatment for each agent but does not provide specific outcomes data.", "population_specificity": "Patients experiencing toxicity from calcium channel blockers, beta blockers, or digoxin, particularly those with bradycardia and hypotension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:44.822981+00:00"}
{"study_id": 183164, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare calcium levels in blood and teeth samples of children with congenital heart defects (CHD) versus healthy controls.", "results_summary": "Children with CHD had significantly lower teeth calcium levels and calcium/phosphorus ratios compared to healthy controls. No significant differences in blood calcium levels were reported.", "population_specificity": "39 children with CHD (11 cyanotic, 28 acyanotic) and 42 age- and sex-matched healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:45.299509+00:00"}
{"study_id": 183166, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine whether plasma levels of calcium and other trace elements differed between individuals with neovascular age-related macular degeneration (nAMD) and age-matched controls.", "results_summary": "The study did not report any significant findings or associations specifically related to calcium levels in nAMD patients compared to controls.", "population_specificity": "236 individuals with nAMD and 236 age-matched controls without AMD.", "effective_dosage": "Not available", "study_duration": "Not applicable (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:46.413327+00:00"}
{"study_id": 183167, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy of a training intervention for general practitioners (GPs) to improve their awareness and prescription practices regarding dietary calcium and supplements.", "results_summary": "The training intervention significantly increased GPs' prescription rates of calcium and vitamin D supplements (from 6.6% to 28% and 24.5% to 78%, respectively), but did not improve dietary calcium intake among patients.", "population_specificity": "General practice outpatients from the same sanitary district.", "effective_dosage": "Not specified", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:46.890180+00:00"}
{"study_id": 183168, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy of two doses of vitamin D supplementation during pregnancy on maternal and cord blood vitamin D status and metabolic and oxidative stress biomarkers, including calcium levels.", "results_summary": "The study found that vitamin D supplementation significantly improved vitamin D status and HDL-C levels while decreasing iPTH levels, but specific effects on calcium were not detailed in the abstract.", "population_specificity": "Pregnant women (n=84)", "effective_dosage": "1000 IU/d and 2000 IU/d vitamin D", "study_duration": "Until 34 weeks of gestation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:49.071931+00:00"}
{"study_id": 183169, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of vitamin D and calcium supplementation on bone mineral density (BMD) among Thai youth receiving daily oral PrEP.", "results_summary": "The study found that youth receiving vitamin D and calcium supplementation had significantly greater increases in lumbar spine BMD compared to those not supplemented, particularly among those with vitamin D deficiency. A higher proportion of supplemented youth showed >3% increase in BMD at six months.", "population_specificity": "Thai male youth aged 15-24 years receiving daily oral PrEP.", "effective_dosage": "1200 mg of elemental calcium per day, divided into two doses with meals.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:51.391528+00:00"}
{"study_id": 183172, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between obesity and alterations in calcium levels and signaling pathways.", "results_summary": "The study found that calcium signaling is disturbed in obesity, likely due to increased reactive oxygen species and low levels of fast troponin isoform. The relationship between obesity and calcium levels requires further research.", "population_specificity": "Individuals with obesity or excess body mass.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:51.632129+00:00"}
{"study_id": 183171, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether vitamin K2 (MK-7) as an add-on to calcium and vitamin D supplementation could improve osteocalcin carboxylation, bone mass, and microarchitecture in postmenopausal women with osteopenia.", "results_summary": "The study found that while MK-7 increased carboxylation of osteocalcin, it did not significantly affect bone mineral density, bone turnover markers, or microarchitecture over 3 years compared to placebo, despite both groups receiving calcium and vitamin D.", "population_specificity": "Postmenopausal women with osteopenia (n=142).", "effective_dosage": "800 mg/day calcium (alongside 38 \u03bcg/day vitamin D3 and 375 \u03bcg/day MK-7 or placebo).", "study_duration": "3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:53.272395+00:00"}
{"study_id": 183173, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily calcium supplementation alters the risk of basal cell carcinoma (BCC) or invasive cutaneous squamous cell carcinoma (SCC).", "results_summary": "Calcium supplementation showed no effect on BCC incidence but suggested a potential reduction in SCC risk, particularly when combined with vitamin D. The effect on SCC was statistically suggestive but not definitive.", "population_specificity": "2259 men and women aged 45-75 years, recently diagnosed with a colorectal adenoma.", "effective_dosage": "1200 mg/d of calcium carbonate", "study_duration": "3 or 5 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:53.634741+00:00"}
{"study_id": 183174, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review existing studies on prenatal maternal diet, including Calcium, and its potential association with autism spectrum disorder (ASD).", "results_summary": "Only one study on Calcium was included in the review, and evidence for its role in ASD was deemed insufficient or inconclusive. No specific findings about Calcium's effects were highlighted.", "population_specificity": "Pregnant women and their offspring, focusing on neurodevelopmental outcomes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:53.636088+00:00"}
{"study_id": 183170, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of vitamin D and calcium co-supplementation in reducing fracture risk and improving bone health, particularly in elderly populations.", "results_summary": "The study found that vitamin D monotherapy does not reduce fracture risk, but co-supplementation with calcium (1000-1200 mg/day) at daily doses of at least 800 IU vitamin D may modestly benefit elderly individuals with severe vitamin D deficiency. High vitamin D doses without calcium appeared harmful for falls and fracture risk.", "population_specificity": "Elderly populations, especially those with severe vitamin D deficiency [25(OH)D <25-30 nmol/L (<10-12 ng/mL)].", "effective_dosage": "1000-1200 mg/day calcium co-supplemented with at least 800 IU/day vitamin D.", "study_duration": "At least 3-5 years of therapy required.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:54.766160+00:00"}
{"study_id": 183175, "supplement_id": 969, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate adherence strategies and effectiveness of different calcium supplementation regimens (varying in dose and timing) for preventing preeclampsia in pregnant women in Ethiopia.", "results_summary": "Adherence rates were similar across regimens (2, 3, or 4 pill-taking events), but the 3-event regimen yielded the highest calcium consumption. Chewable supplements were initially preferred but declined over time, and social stigma around midday dosing was a barrier.", "population_specificity": "Pregnant women in Ethiopia.", "effective_dosage": "1.5-2 g/d, divided into 2, 3, or 4 daily doses.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:55.771175+00:00"}
{"study_id": 183176, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to identify practices related to hypocalcemia prevention and management in pediatric patients post-thyroidectomy.", "results_summary": "The study found a high incidence of hypocalcemia (35.5% transient, 4.2% permanent) in children post-thyroidectomy, with significant variation in prevention and management practices. Most patients required intravenous calcium therapy, and only one study described a protocol for discharging asymptomatic patients on calcitriol and calcium.", "population_specificity": "Pediatric patients undergoing thyroidectomy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:57.119710+00:00"}
{"study_id": 183178, "supplement_id": 969, "safety_score": "80", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the effects of phytotherapeutic and herbal medicines, including Phyllanthus niruri and theobromine, on calcium oxalate and uric acid kidney stones.", "results_summary": "Phyllanthus niruri was found to interfere with calcium oxalate crystallization, reduce hyperoxaluria and hyperuricosuria, and enhance shock wave lithotripsy efficacy without significant adverse effects. Theobromine showed promise in reducing uric acid crystallization.", "population_specificity": "Patients with calcium oxalate and uric acid kidney stones, as well as animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:13:59.987743+00:00"}
{"study_id": 183177, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the impact of regional citrate anticoagulation (RCA) on magnesium levels in critically ill patients undergoing kidney replacement therapy (KRT) and explore strategies to mitigate hypomagnesemia.", "results_summary": "The study found that RCA in KRT leads to magnesium loss, potentially causing hypomagnesemia, and suggested that adjusting dialysis solutions or early intravenous magnesium supplementation could help manage this issue.", "population_specificity": "Critically ill patients with acute kidney injury (AKI) requiring continuous or prolonged intermittent kidney replacement therapy (CKRT/PIKRT).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:00.131854+00:00"}
{"study_id": 183179, "supplement_id": 969, "safety_score": "70", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of calcium supplementation, alone and in combination with other nutrients, in managing osteoporosis and age-related bone and muscle loss.", "results_summary": "Calcium supplementation alone is not recommended for fracture prevention in the general postmenopausal population but may benefit those with insufficient dietary intake and absorption. Customization is needed due to potential side effects and adherence issues.", "population_specificity": "Postmenopausal women and patients at risk of fracture with insufficient dietary calcium intake.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:01.023445+00:00"}
{"study_id": 183182, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the mechanistic findings of usnic acid (UA)-induced hepatotoxicity and cell death, including its effects on calcium-related signaling pathways.", "results_summary": "The study found that UA induces hepatotoxicity through oxidative stress, ATP depletion, and activation of various signaling pathways, including store-operated calcium entry, but did not specifically evaluate calcium's role in safety or efficacy.", "population_specificity": "Experimental rat liver tissues (animal model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:02.347309+00:00"}
{"study_id": 183181, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of calcium in managing CKD-induced mineral bone disorder (MBD) and osteoporosis, focusing on prevention and treatment strategies.", "results_summary": "The study highlights the importance of calcium supplementation alongside lifestyle modifications in managing CKD-MBD, but emphasizes the need for patient-centered approaches due to varying types of renal osteodystrophy. It also notes the necessity of managing hyperphosphatemia and secondary hyperparathyroidism (SHPT) alongside calcium use.", "population_specificity": "Patients with chronic kidney disease (CKD) and associated mineral bone disorder (MBD) or osteoporosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:02.640725+00:00"}
{"study_id": 183183, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify healthcare service combinations, including calcium supplementation, associated with recovery of health-related quality of life (HRQoL) 12 months post-major osteoporotic fracture.", "results_summary": "Calcium supplementation, when combined with other healthcare services like hospital presentations, outpatient visits, and non-opioid analgesic use, was associated with increased odds of HRQoL recovery at 12 months post-fracture. Similar patterns were observed for non-hip fractures.", "population_specificity": "Adults aged \u226550 years with major osteoporotic fractures (hip, distal forearm, vertebrae, humerus) from 11 countries.", "effective_dosage": "Not specified", "study_duration": "12 months post-fracture", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:04.289896+00:00"}
{"study_id": 183184, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of magnesium supplementation compared to no treatment, placebo, or other therapies for skeletal muscle cramps, including comparisons involving calcium.", "results_summary": "The study found no statistically significant benefit of magnesium over placebo for idiopathic cramps in older adults. For pregnancy-associated cramps, results were conflicting, and no conclusive evidence supported magnesium's efficacy. Calcium comparisons were limited and inconclusive.", "population_specificity": "Older adults with idiopathic cramps, pregnant women with leg cramps, and a small group with liver cirrhosis.", "effective_dosage": "Not specified for calcium.", "study_duration": "Four weeks for primary outcomes.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:05.688301+00:00"}
{"study_id": 183186, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify risk factors, protective factors, and controversial factors related to postpartum depression, including the role of calcium as a potential protective factor.", "results_summary": "Calcium was identified as one of the protective factors against postpartum depression, alongside other nutrients like Vitamin D, zinc, and selenium. The study did not provide specific details on the magnitude of calcium's effect but grouped it with other beneficial dietary components.", "population_specificity": "Postpartum women at risk for or experiencing postpartum depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:08.226494+00:00"}
{"study_id": 183187, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplemental calcium (1,200 mg/day) affects COX-2 and 15-HPGD expression in the rectal mucosa of patients with colorectal adenoma.", "results_summary": "The study found that calcium supplementation, either alone or combined with vitamin D, reduced the COX-2/15-HPGD expression ratio, suggesting a potential anti-inflammatory and anti-carcinogenic effect in colorectal tissue.", "population_specificity": "62 patients with a history of colorectal adenoma.", "effective_dosage": "1,200 mg/day", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:09.528965+00:00"}
{"study_id": 183185, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether replacing animal proteins with plant-based proteins affects bone and mineral metabolism, particularly calcium and vitamin D levels, in healthy adults.", "results_summary": "The study found that a plant-based diet increased markers of bone resorption and formation, likely due to lower calcium and vitamin D intakes, suggesting a potential risk for bone health. No significant adverse effects were reported, but calcium and vitamin D intakes were below recommended levels in the plant-based group.", "population_specificity": "107 women and 29 men, aged 20-69, with a mean BMI of 24.8 \u00b1 3.9.", "effective_dosage": "Not specified (dietary intake assessed, not supplementation).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:09.530848+00:00"}
{"study_id": 183189, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to review the current understanding of vitamin D's role in the cardiovascular system and explain discrepancies between experimental and clinical intervention studies.", "results_summary": "Observational studies linked vitamin D deficiency to cardiovascular risks, but clinical trials did not confirm causal benefits of supplementation. Animal studies suggested vitamin D is essential for cardiovascular integrity.", "population_specificity": "General population, with implications for those at risk of cardiovascular diseases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:09.997961+00:00"}
{"study_id": 183188, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the appropriateness of ordering serum albumin levels in critically ill patients, including its use for estimating free calcium levels.", "results_summary": "The study found that serum albumin levels are commonly ordered in ICU settings to estimate free calcium levels, but there is little evidence to justify routine ordering of albumin levels for this purpose in critically ill patients.", "population_specificity": "Adult critically ill patients in intensive care unit (ICU) settings.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:10.417075+00:00"}
{"study_id": 183191, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers examined whether high calcium intake and vitamin D supplementation could prevent bone degradation during bed rest or spaceflight.", "results_summary": "High calcium intake and vitamin D supplementation were not beneficial for preventing bone degradation during bed rest or spaceflight. The study suggests further investigation into vitamin K supplementation for bone health.", "population_specificity": "Individuals undergoing bed rest (as a model for spaceflight)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:13.508471+00:00"}
{"study_id": 183180, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether electrolyte supplementation (including Calcium) reduces kidney injury in patients receiving cisplatin-based chemotherapy.", "results_summary": "Electrolyte supplementation (Magnesium, Calcium, and Potassium) significantly reduced nephrotoxicity incidence (20.41% vs. 54% in the control group) and improved survival outcomes in cisplatin-treated patients.", "population_specificity": "Patients with confirmed solid tumors receiving cisplatin-based chemotherapy at Ocean Road Cancer Institute.", "effective_dosage": "Not specified (intravenous normal saline supplemented with Magnesium, Calcium, and Potassium).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:14.851059+00:00"}
{"study_id": 183190, "supplement_id": 969, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine bone-related nutrition and bone turnover markers in adolescents after sleeve gastrectomy (SG) compared to laparoscopic adjustable gastric band (LAGB).", "results_summary": "Calcium and 25 OHD levels increased at 6 and 12 months after both surgeries, with no difference between them. SG patients showed increased bone turnover markers (osteocalcin and CTX), though CTX decreased between 6 and 12 months, and these changes were not linked to 25 OHD deficiency, hypocalcemia, or hyperparathyroidism.", "population_specificity": "Adolescents who underwent metabolic and bariatric surgery (SG or LAGB).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:15.262521+00:00"}
{"study_id": 8530, "supplement_id": 994, "safety_score": "80", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy of CDP-Choline in treating tardive dyskinesia in elderly patients with a history of long-term neuroleptic treatment.", "results_summary": "The study found statistically significant reductions in symptomatology using Simpson's abbreviated scale after four weeks of CDP-Choline treatment. The drug's tolerance was reported as satisfactory.", "population_specificity": "Patients older than 60 years with tardive dyskinesia due to long-term neuroleptic use.", "effective_dosage": "500-1200 mg daily", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:23.662335+00:00"}
{"study_id": 8524, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of CDP-choline on striatal dopamine synthesis and nigrostriatal dopaminergic neuron function in rats.", "results_summary": "Acute CDP-choline administration increased striatal dopamine synthesis, while chronic treatment reduced 3H-spiroperidol binding sites and partially countered the loss of DA-sensitive adenylate cyclase activity caused by kainic acid. The findings suggest CDP-choline may have a trophic or stimulant effect on nigrostriatal dopaminergic neurons.", "population_specificity": "Rats", "effective_dosage": "Not specified", "study_duration": "Chronic treatment duration not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:23.783135+00:00"}
{"study_id": 8528, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of CDP-choline on lipid synthesis and its distribution in different brain areas of aged rats.", "results_summary": "CDP-choline administration increased radioactivity enrichment in brain areas (except the cerebral cortex) and improved labeled glycerol incorporation in the cortex, though it decreased in other areas due to a dilution effect. The (3H)/(14C) ratio in total lipid and specific phospholipids increased after CDP-choline treatment.", "population_specificity": "12-month-old male rats", "effective_dosage": "Not specified", "study_duration": "Single dose administered 10 minutes before sacrifice", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:23.880078+00:00"}
{"study_id": 8521, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the presence and activity of CDP-choline: diacylglyceride phosphocholine transferase in rat liver nuclear membranes and its response to hydrocortisone treatment.", "results_summary": "The study found that the enzyme activity in nuclear membranes was less than one-third of that in microsomes. Hydrocortisone treatment increased enzyme activity in microsomes but decreased it in nuclear membranes, suggesting a role in nuclear membrane structure during cellular functional changes.", "population_specificity": "Rat liver nuclear membranes and microsomes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:23.904632+00:00"}
{"study_id": 8529, "supplement_id": 994, "safety_score": "90", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety and efficacy of oral CDP-Choline in treating neurological conditions, primarily vasculocerebral insufficiency and senile involution.", "results_summary": "CDP-Choline showed significant improvements in symptoms like dizziness, cephalea, insomnia, depression, and memory shortage, with the best results in chronic cerebrovascular insufficiency. Side effects were minimal, occurring in only 5.01% of patients, mostly digestive issues.", "population_specificity": "2817 patients of all ages, predominantly 60-80 years old, with neurological conditions.", "effective_dosage": "Mean dose of 6 ml/day.", "study_duration": "15 days to 2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:24.070201+00:00"}
{"study_id": 8523, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of acute and chronic CDP-choline treatment on platelet aggregation, thromboxane formation, and the antiaggregatory activity of thoracic aorta in rats.", "results_summary": "Acute CDP-choline treatment reduced platelet reactivity without altering thromboxane formation, while chronic treatment increased the antiaggregatory activity of the vessel wall without affecting platelet function. The study suggests CDP-choline has favorable effects, particularly in acute treatment, by reducing platelet reactivity.", "population_specificity": "Rats", "effective_dosage": "250 mg/kg (acute and chronic)", "study_duration": "Acute: single dose; Chronic: two weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:24.458265+00:00"}
{"study_id": 8526, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the therapeutic effects of CDP-choline on restoring phosphatidylcholine (PC) levels in pulmonary surfactant and improving alveolar gas exchange in patients with pulmonary fibrosis and sarcoidosis.", "results_summary": "After one month of CDP-choline treatment, PC levels normalized, and improvements in PaO2 (both at rest and after exercise) were observed. Long-term administration appeared beneficial for maintaining phospholipid equilibrium and enhancing gas exchange.", "population_specificity": "Patients with diffuse interstitial pulmonary fibrosis or pulmonary sarcoidosis with parenchymal involvement.", "effective_dosage": "1 g intramuscularly per day", "study_duration": "One month (with long-term administration implied)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:24.753241+00:00"}
{"study_id": 8522, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether CDP-choline could protect neuronal cultures from hypocapnic injury and assess its effects on cellular proliferation.", "results_summary": "CDP-choline protected neuronal cultures from hypocapnic injury when administered before or after the injury, maintaining cell aggregates and neuronal processes. The intact molecule was essential for protection, as other nucleosides, nucleotides, and choline derivatives were ineffective. CDP-choline also reduced hypocapnia-induced phospholipid incorporation of radioactive choline.", "population_specificity": "Neuronal cultures from chick embryo cerebral hemispheres", "effective_dosage": "10^(-6) M CDP-choline", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:25.697933+00:00"}
{"study_id": 8534, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether CDP-choline could protect against experimental toxicity induced by potassium cyanide.", "results_summary": "Animals pretreated with CDP-choline showed protection against potassium cyanide-induced toxicity. The study suggests CDP-choline has a preventive effect in this experimental model.", "population_specificity": "Animals (species not specified)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:30.469053+00:00"}
{"study_id": 8533, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine the efficacy of oral CDP-choline in reducing parasympathetic stimulation effects (sialorrhea, diarrhea, hypothermia) induced by oxotremorine in mice.", "results_summary": "CDP-choline treatment decreased sialorrhea, diarrhea, and hypothermia caused by oxotremorine administration in mice.", "population_specificity": "Mice (animal study)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:30.812807+00:00"}
{"study_id": 8535, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether oral CDP-Choline could reduce the intensity of experimental withdrawal syndrome.", "results_summary": "The study found that CDP-Choline treatment decreased the intensity of withdrawal syndrome using two different experimental methods. Both methods consistently showed a reduction in withdrawal symptoms.", "population_specificity": "Experimental (animal or human not specified)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:30.928843+00:00"}
{"study_id": 8532, "supplement_id": 994, "safety_score": "85", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the safety and potential toxic effects of CDP-Choline in Beagle dogs over a 6-month period.", "results_summary": "The study found no toxic effects from CDP-Choline, with urinalysis, blood analysis, and histopathological results within normal ranges, aside from slight individual variability.", "population_specificity": "Beagle dogs", "effective_dosage": "1.5 g/kg daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:31.151192+00:00"}
{"study_id": 8531, "supplement_id": 994, "safety_score": "85", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to determine the acute effects of intraduodenal CDP-choline on cardiovascular and respiratory parameters in anesthetized rats.", "results_summary": "CDP-choline did not affect heart or respiratory rates compared to controls. Arterial pressure and respiratory flow remained near basal values, with inspiratory flow showing a statistically significant difference (closer to basal) compared to the decrease in controls.", "population_specificity": "Anesthetized rats", "effective_dosage": "Not specified", "study_duration": "Acute (single administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:31.217697+00:00"}
{"study_id": 8536, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether repeated oral administration of CDP-Choline could protect against the effects of acute mechanical brain compression in anesthetized cats.", "results_summary": "CDP-Choline-treated cats showed significantly increased resistance to brain compression effects, delayed onset of abnormal EEG waveforms, and protection against cardiovascular and respiratory failure compared to the vehicle-treated group. The compound also provided statistically significant protection against lethal effects of epidural compression.", "population_specificity": "Anesthetized cats subjected to epidural brain compression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:31.941172+00:00"}
{"study_id": 8537, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to determine whether CDP-choline could prevent changes in brain lipid metabolism caused by ischemia in gerbils.", "results_summary": "CDP-choline partially corrected the increase in diglyceride pool and its arachidonate labeling caused by ischemia, but did not alter the increase in free fatty acids. It also partially restored the decrease in phosphatidylcholine labeling.", "population_specificity": "Gerbils (Meriones unguiculatus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:32.592783+00:00"}
{"study_id": 8538, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether CDP-choline improves symptoms in Parkinson's patients already treated with L-dopa and a dopa decarboxylase inhibitor, focusing on its potential action on dopamine receptors via phospholipid metabolism.", "results_summary": "CDP-choline significantly improved rigidity and bradykinesia, with a lesser effect on tremor, as measured by clinical scales (WRS, NUDS). Compared to placebo, it showed 23% and 33% improvement in bradykinesia and rigidity, respectively.", "population_specificity": "Parkinsonian patients already on L-dopa + dopa decarboxylase inhibitor therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:34.209148+00:00"}
{"study_id": 8540, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether CDP-choline could reverse the effects of hypoxia on DNA, RNA, and protein labeling in different brain regions of guinea pigs.", "results_summary": "CDP-choline did not reverse hypoxia's effect on DNA labeling but restored RNA and protein labeling, particularly in cerebellar nuclei/mitochondria (RNA) and microsomes across brain regions (proteins).", "population_specificity": "Guinea pigs subjected to hypoxic treatment.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:39.474160+00:00"}
{"study_id": 8541, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of estrogen treatment on the enzymatic pathways involved in phosphatidylcholine synthesis, particularly focusing on CDP-Choline's role in fetal lung development.", "results_summary": "Estrogen treatment increased CDP-Choline and phosphatidylcholine levels in fetal lung, suggesting enhanced cholinephosphate cytidylyltransferase activity. The study indicates CDP-Choline's regulatory role in phosphatidylcholine synthesis during fetal lung development.", "population_specificity": "Pregnant rabbits and their fetuses (term = 31 days gestation).", "effective_dosage": "Not specified", "study_duration": "Administered at 25 days gestation (term = 31 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:40.068038+00:00"}
{"study_id": 8539, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CDP-choline could mitigate the effects of brain ischemia, specifically by preventing the release of free fatty acids and stimulating phosphatidylcholine synthesis.", "results_summary": "CDP-choline corrected the increase in total and individual fatty acids due to ischemia, reversed the decrease in brain phosphatidylcholine, and prevented the release of arachidonic acid. The nucleotide also corrected changes in neutral lipids, particularly diacylglycerol.", "population_specificity": "Gerbils (Meriones unguiculatus) with induced brain ischemia", "effective_dosage": "0.6 micromol/brain (3 microliter, single intraventricular injection)", "study_duration": "Single dose administered 5 minutes before arterial ligation, effects measured 10 minutes post-ligation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:40.294425+00:00"}
{"study_id": 8544, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of intrathecal infusion of CDP-choline as a brain activator, considering blood-brain and CSF-brain barriers, in both clinical and animal models.", "results_summary": "The study examined seven patients with consciousness disturbances due to brain lesions, showing neurological and electroencephalographic effects from CDP-choline infusion. Animal experiments using Wistar rats demonstrated the distribution of 14C-CDP-choline via different administration routes.", "population_specificity": "Seven patients with primary brain lesions causing consciousness disturbances and Wistar rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:40.423270+00:00"}
{"study_id": 8543, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CDP-choline could correct impaired lipid metabolism in specific brain regions caused by hypoxia.", "results_summary": "CDP-choline administration increased the specific radioactivity of total lipids and phospholipids in mitochondria from cerebral hemispheres, cerebellum, and brainstem of hypoxic animals, particularly enhancing the incorporation of labeled precursors into mitochondrial PC, PE, and polyglycerophosphatides. The effect was most pronounced in mitochondria, the subcellular fraction most affected by hypoxia.", "population_specificity": "Hypoxic animals (specific species not mentioned in the abstract).", "effective_dosage": "100 mg/kg body weight (intraperitoneal injection).", "study_duration": "Single acute administration (10 minutes before precursor injection).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:40.663728+00:00"}
{"study_id": 8542, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of CDP-choline on Parkinsonian symptoms by measuring striatal dopamine levels and behavioral changes in rats with induced nigro-striatal dopamine neuron degeneration.", "results_summary": "CDP-choline increased striatal dopamine content and modulated behavioral responses in rats, suppressing apomorphine-induced and d-amphetamine-induced circling at higher doses but enhancing apomorphine-induced circling after prolonged treatment. The results suggest CDP-choline may act as an antagonist on dopamine neurons and receptors.", "population_specificity": "Rats with unilateral nigro-striatal dopamine neuron degeneration induced by 6-hydroxydopamine (6-OHDA).", "effective_dosage": "300 mg/kg and 900 mg/kg, intraperitoneal injection.", "study_duration": "Single dose and 7-day consecutive treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:41.450330+00:00"}
{"study_id": 59869, "supplement_id": 994, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the cytoprotective effects of CDP-choline in experimental models of heart, liver, and kidney acute damage, particularly in the context of cardiogenic shock.", "results_summary": "CDP-choline demonstrated cytoprotective effects by reducing reperfusion-induced ventricular arrhythmias, oxidative stress, apoptotic cell death, inflammation, lactic acid levels, and preserving mitochondrial function in experimental models. The study suggests CDP-choline has potential as an adjuvant therapy to mitigate organ damage in cardiogenic shock.", "population_specificity": "Experimental models of heart, liver, and kidney acute damage (not specified if human or animal).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:41.648156+00:00"}
{"study_id": 59872, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether CDP-choline could exert neuroprotective and neuroreparative effects in methamphetamine-dependent patients, specifically examining its impact on brain structures, craving, and MA use.", "results_summary": "CDP-choline significantly reduced craving for MA and increased gray matter volumes in key brain regions (left middle frontal gyrus, right hippocampus, left precuneus), with these changes correlating with reduced craving and increased MA-negative urine results. However, there was no significant difference in total MA-negative urine samples between CDP-choline and placebo groups.", "population_specificity": "Methamphetamine-dependent patients (n=44) and healthy controls (n=27).", "effective_dosage": "2 g/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:43.137469+00:00"}
{"study_id": 59873, "supplement_id": 994, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of citicoline (CDP-choline) on memory in healthy elderly individuals with age-associated memory impairment (AAMI).", "results_summary": "Citicoline supplementation significantly improved episodic memory and composite memory scores compared to placebo after 12 weeks, with no major safety concerns reported.", "population_specificity": "Healthy men and women aged 50-85 years with AAMI.", "effective_dosage": "500 mg/d", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:47.216662+00:00"}
{"study_id": 59875, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to synthesize existing evidence on the efficacy of citicoline as an adjunct therapy in improving Parkinson's disease symptoms.", "results_summary": "The review found that citicoline significantly improved rigidity, akinesia, tremor, handwriting, speech, and cognitive status in PD patients, while also allowing a 50% reduction in levodopa dosage. However, study heterogeneity was noted.", "population_specificity": "Patients with Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:47.470136+00:00"}
{"study_id": 59882, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to investigate whether early and consistent citicoline (CDP-choline) administration improved outcomes in traumatic brain injury (TBI) patients.", "results_summary": "The study found significantly reduced ICU mortality (5% vs. 24%), in-hospital mortality (9% vs. 24%), 6-month mortality (13% vs. 28%), and unfavorable outcomes (34% vs. 57%) in TBI patients treated with citicoline compared to matched controls.", "population_specificity": "TBI patients with Glasgow Coma Scale score <13 and/or Abbreviated Injury Scale of the head >2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:48.943088+00:00"}
{"study_id": 59876, "supplement_id": 994, "safety_score": "100", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the neuroprotective effect of citicoline (CDP-Choline) in children after cardiac arrest.", "results_summary": "Citicoline significantly improved Glasgow Coma Score (GCS) and modified Rankin Scale (mRS), reduced seizure frequency and duration, decreased mortality, shortened PICU and hospital stays, and lowered serum neuron-specific enolase (NSE) levels compared to the control group, with no reported side effects.", "population_specificity": "80 children surviving in-hospital cardiac arrest, aged unspecified, treated in pediatric and surgical ICUs.", "effective_dosage": "10 mg/kg every 12 hours intravenously.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:49.256711+00:00"}
{"study_id": 59883, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 82, "study_goal": "The researchers aimed to analyze phosphatidylcholine species, including CDP-choline, in hepatocellular carcinoma (HCC) tumors compared to adjacent liver tissue and intrahepatic cholangiocarcinoma (ICC) tumors to understand their metabolic dependencies.", "results_summary": "The study found significantly higher levels of CDP-choline and highly saturated phosphatidylcholine species in HCC tumors compared to adjacent liver and ICC tumors, suggesting a reliance on de novo fatty acid metabolism for phospholipid synthesis in HCC.", "population_specificity": "31 HCC patients and 4 ICC patients.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:50.603659+00:00"}
{"study_id": 59884, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the roles of choline kinase isoforms (CHK\u03b1 and CHK\u03b2) and the potential therapeutic applications of CDP-choline in treating muscular dystrophy, bone deformities, cognitive conditions, and cancer.", "results_summary": "The study highlights that CHK\u03b1 may serve as a cancer biomarker and its inhibition as a potential anti-cancer therapy, while CHK\u03b2 deficiency restoration via CDP-choline supplementation could benefit muscular dystrophy, bone metabolic diseases, and cognitive conditions. The differential roles of choline kinase isoforms and their therapeutic potential are discussed.", "population_specificity": "Not specified (general discussion of molecular and physiological roles).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:50.789171+00:00"}
{"study_id": 59885, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess whether citicoline treatment initiated within 14 days after stroke onset improves outcomes in acute ischemic stroke patients compared to placebo.", "results_summary": "Citicoline was associated with a significantly higher rate of independence, particularly in patients not treated with rtPA, though its benefit was limited when added to the best available treatment (rtPA). The effect size varied based on dosage and timing, with stronger effects observed in subgroups receiving higher doses within 24 hours.", "population_specificity": "Patients with acute ischemic stroke.", "effective_dosage": "Highest dose (specific amount not stated) started within 24 hours.", "study_duration": "Not specified.", "interactions": "Interaction with rtPA noted (reduced citicoline efficacy when combined).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:50.899828+00:00"}
{"study_id": 59888, "supplement_id": 994, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "To review the literature on citicoline's use in addictive disorders, focusing on its safety, efficacy, and potential benefits for craving, withdrawal symptoms, and cognitive functioning.", "results_summary": "Citicoline was found to be safe and well tolerated, with evidence suggesting it decreases craving and reduces cocaine use, particularly at high doses in patients with bipolar disorder and cocaine dependence. Limited data also indicate potential benefits for alcohol and cannabis dependence and reduced food consumption.", "population_specificity": "Patients with addictive disorders, primarily cocaine dependence, and some studies on alcohol and cannabis dependence.", "effective_dosage": "High doses (specific amount not mentioned)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:51.470902+00:00"}
{"study_id": 59889, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to critically discuss the clinical pharmacology of citicoline, including its pharmacokinetics, biotransformation, pharmacodynamics, and mode of action.", "results_summary": "Citicoline showed neuroprotective effects in preclinical models of brain ischemia and trauma but failed to demonstrate benefits in large clinical trials for ischemic stroke and traumatic brain injury. However, it appeared beneficial in slowly progressing neurodegenerative disorders like glaucoma and mild vascular cognitive impairment.", "population_specificity": "Preclinical models and clinical trials involving ischemic stroke, traumatic brain injury, glaucoma, and mild vascular cognitive impairment.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:55.616705+00:00"}
{"study_id": 59891, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of PEMT in phosphatidylcholine synthesis and its implications for hepatic membrane integrity, lipid metabolism, and metabolic disorders.", "results_summary": "The study found that PEMT is essential for maintaining hepatic membrane integrity, choline formation during dietary choline deficiency, and normal VLDL secretion. PEMT deficiency protected against diet-induced atherosclerosis, obesity, and insulin resistance but increased susceptibility to fatty liver and steatohepatitis.", "population_specificity": "Mice (animal model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:56.822276+00:00"}
{"study_id": 59892, "supplement_id": 994, "safety_score": "70", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining CDP-choline with galantamine could improve negative symptoms and cognitive function in schizophrenia patients by enhancing \u03b17 nAChR signaling.", "results_summary": "The study found no significant treatment effect on negative symptoms or cognitive measures, but there were improvements in overall functioning and verbal recall. Adverse events included gastrointestinal issues in the active treatment group.", "population_specificity": "Schizophrenia patients with negative symptoms receiving second-generation antipsychotics.", "effective_dosage": "Not specified", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:57.564113+00:00"}
{"study_id": 59890, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of long-chain polyunsaturated fatty acids (LCPUFA) in neural development, aging, and neurodegenerative diseases, focusing on their impact on cognition, inflammation, and brain health.", "results_summary": "The review highlights that LCPUFA, including docosahexaenoic acid and arachidonic acid, are crucial for neural development, cognitive function, and prevention of neurodegeneration. Perinatal supplementation showed benefits in cognition and sensorimotor integration, while LCPUFA also demonstrated potential in reducing neurodegeneration and inflammation in conditions like Alzheimer's and Parkinson's disease.", "population_specificity": "Humans and rodents (broadly, from perinatal stages to aging and neurodegenerative conditions).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:59.008687+00:00"}
{"study_id": 59898, "supplement_id": 994, "safety_score": "85", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review clinical trials on CDP-Choline's effects on cognitive decline, particularly in vascular cognitive impairment and Alzheimer's disease.", "results_summary": "CDP-Choline showed beneficial effects on several cognitive domains, but methodological heterogeneity across studies made it difficult to draw definitive conclusions. New trials with standardized criteria and neuroimaging are needed for clearer evidence.", "population_specificity": "Patients with vascular cognitive impairment and Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Medium and long-term (specific duration not provided)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:59.543726+00:00"}
{"study_id": 59897, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether uridine administration affects membrane phospholipid precursors (like CDP-Choline) in healthy adults, as measured by phosphorus magnetic resonance spectroscopy.", "results_summary": "Uridine significantly increased phosphomonoesters (PME) and phosphoethanolamine (PEtn) levels after one week, but no significant changes were observed in other metabolites like phosphocholine (PCho) or phosphodiesters (PDE).", "population_specificity": "17 healthy males (mean age 32.73 \u00b1 7.2 years).", "effective_dosage": "2 g of uridine daily.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:59.617843+00:00"}
{"study_id": 59894, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of citicoline (CDP-Choline) in improving cognitive and mental performance in geriatric patients with sub-acute ischemic cerebrovascular disease, including those with dementia.", "results_summary": "The study found that oral citicoline (500-4000 mg/day) improved general conditions post-ischemic stroke, as measured by the Rankin scale and NIH Stroke Scale. It also enhanced cognitive and mental performance in Alzheimer's and vascular dementia.", "population_specificity": "Geriatric patients with sub-acute ischemic cerebrovascular disease, with or without cognitive decline and behavioral symptoms.", "effective_dosage": "500-4000 mg/day (oral)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:14:59.870914+00:00"}
{"study_id": 59893, "supplement_id": 994, "safety_score": "75", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the roles of choline-containing phospholipids (CCPLs), including CDP-choline, in brain metabolism and assess their potential therapeutic effects in cerebrovascular or neurodegenerative disorders with cholinergic impairment.", "results_summary": "The study found that CDP-choline and choline alphoscerate (GPC) showed promising effects in preclinical studies and limited clinical trials for disorders with impaired cholinergic neurotransmission, suggesting they may still have a place in pharmacotherapy despite earlier negative results with other CCPLs.", "population_specificity": "Cerebrovascular or neurodegenerative disorders characterized by cholinergic neurotransmission impairment (e.g., Alzheimer's disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:00.189901+00:00"}
{"study_id": 59899, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether CDP-choline treatment could alter neurometabolite levels (NAA and Cho) in methamphetamine-dependent patients and whether these changes correlated with reduced drug use.", "results_summary": "CDP-choline treatment significantly increased prefrontal NAA and Cho levels compared to placebo, with NAA changes positively associated with fewer positive urine results, suggesting potential neuroprotective effects linked to reduced drug use.", "population_specificity": "Methamphetamine-dependent patients seeking treatment (n=31).", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:05.425063+00:00"}
{"study_id": 196995, "supplement_id": 994, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the cognitive effects of CDP-choline in healthy volunteers, particularly its potential to improve schizophrenia-relevant cognitive domains via \u03b17 nAChR agonism.", "results_summary": "CDP-choline improved processing speed, working memory, verbal learning, verbal memory, and executive function in low baseline performers, had no effect in medium performers, and diminished cognition in high performers. Dose effects varied by cognitive domain but were evident at both 500mg and 1000mg doses.", "population_specificity": "24 male healthy volunteers", "effective_dosage": "500mg and 1000mg single doses", "study_duration": "Single-dose intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:06.391152+00:00"}
{"study_id": 8824, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuropharmacological activity and efficacy of Celastrus paniculatus oil in improving cognitive impairment induced by scopolamine in rats.", "results_summary": "CP oil improved behavioral deficits, increased biogenic amine levels, reduced oxidative stress and neuroinflammatory markers, and restored synaptic plasticity, demonstrating cognitive enhancement in scopolamine-induced amnesia.", "population_specificity": "Rats with scopolamine-induced cognitive impairment", "effective_dosage": "Not specified", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:06.988484+00:00"}
{"study_id": 8822, "supplement_id": 995, "safety_score": "85", "efficacy_score": 78, "quality_score": 72, "study_goal": "The researchers aimed to investigate the neuroprotective effects and mechanism of Celastrus paniculatus seed extract (CPSE) in an in vitro model of Parkinson's disease (PD) induced by MPP+.", "results_summary": "CPSE showed no adverse effects on cell viability at high concentrations and prolonged treatment. It ameliorated MPP+-induced dopaminergic neuron damage, exhibited anti-apoptotic activity by reversing MPP+-induced inhibition of Bcl-2 expression, and abolished MPP+-induced decreases in phosphorylated-GSK-3\u03b2 (Ser9) expression.", "population_specificity": "Human neuroblastoma SH-SY5Y cells (in vitro study).", "effective_dosage": "Not specified (concentrations used in assays not detailed).", "study_duration": "Not specified (treatment duration not detailed).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:07.524416+00:00"}
{"study_id": 8827, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the phytochemical characteristics, traditional uses, and therapeutic potential of Celastrus paniculatus seeds and seed oil for treating neurological disorders.", "results_summary": "The abstract highlights Celastrus paniculatus's historical use in Ayurveda for neurological conditions like epilepsy, dementia, and cognitive dysfunction, and summarizes research supporting its therapeutic potential against common neurodegenerative diseases.", "population_specificity": "Not specified (review of traditional and research data).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:08.144676+00:00"}
{"study_id": 8826, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effect of Celastrus paniculatus on cognitive function and neuronal apoptosis in glutamate-induced neuronal injury in mice.", "results_summary": "Celastrus paniculatus improved cognitive function, reduced inflammatory cytokines and ROS production, lowered intracellular Ca+ ion concentration, and modulated apoptosis-related proteins (Bax, Bcl-2, caspase-3) in glutamate-injured mice.", "population_specificity": "Neuronal injured mice induced by monosodium glutamate (MSG).", "effective_dosage": "30 mg/kg intraperitoneally (ip) daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:08.349041+00:00"}
{"study_id": 8823, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Celastrus paniculatus seed extract on seizure severity and cognitive deficits in a PTZ-induced chemical kindling model of epilepsy.", "results_summary": "Celastrus paniculatus (500 mg/kg) alone and in combination with other agents significantly reduced seizure scores, improved cognitive performance in the Morris water maze, elevated antioxidant markers (GSH, CAT, SOD), increased dopamine levels, and protected against neuronal loss in the hippocampus and frontal cortex. No significant effect was observed in grip strength.", "population_specificity": "PTZ-induced chemical kindling model (animal study, not human).", "effective_dosage": "500 mg/kg (alone), 250 mg/kg (in combination with pergolide or SVA).", "study_duration": "14 days of treatment following 4 weeks of PTZ kindling induction.", "interactions": "Combined with pergolide (1 mg/kg) and sodium valproic acid (100 mg/kg).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:09.979327+00:00"}
{"study_id": 8825, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Celastrus paniculatus seed oil (CPSO) alone and in combination with fluoxetine (FLU) on depression-like behaviors in a modified chronic unpredictable stress (mCUS) mouse model.", "results_summary": "CPSO, especially in combination with fluoxetine, significantly improved behavioral, biochemical, inflammatory, and neurotransmitter levels in mCUS-induced depression in mice, demonstrating an antidepressant effect. The combination treatments outperformed CPSO or fluoxetine alone.", "population_specificity": "Adult albino mice subjected to a modified chronic unpredictable stress protocol.", "effective_dosage": "CPSO (50 and 100 mg/kg), fluoxetine (10 and 20 mg/kg), and combinations (CPSO 50 + FLU 10, CPSO 100 + FLU 10).", "study_duration": "21 days (from day 16 to day 36).", "interactions": "Positive interaction noted with fluoxetine (enhanced efficacy in combination).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:12.099194+00:00"}
{"study_id": 8828, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of Celastrus paniculatus seed extract against lead-acetate-induced nephrotoxicity by examining histopathological, immunohistochemical, ultrastructural, and PI3K/AKT signaling pathway changes.", "results_summary": "Celastrus paniculatus seed extract (EECP) ameliorated lead-acetate-induced kidney damage, reducing shrunken cells, glomerular atrophy, and renal tubule degeneration. EECP also significantly increased PI3K and AKT mRNA levels, suggesting a protective mechanism via the PI3K/AKT pathway.", "population_specificity": "Rats (24 animals, divided into four groups of 6).", "effective_dosage": "800 mg/kg body weight/day, oral.", "study_duration": "28 consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:15.890980+00:00"}
{"study_id": 8829, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the gastroprotective and antiulcer effects of Celastrus paniculatus seed oil (CPO) in rat models of gastric ulcers.", "results_summary": "CPO demonstrated significant gastroprotective effects against ethanol- and indomethacin-induced ulcers by reducing gastric juice volume, acidity, and proinflammatory cytokines (TNF-\u03b1, IL-6) while increasing gastric pH and anti-inflammatory IL-10. It also decreased oxidative stress markers (MDA) and enhanced antioxidant enzyme activities (SOD, catalase).", "population_specificity": "Rats (pylorus-ligated, ethanol- and indomethacin-induced ulcer models)", "effective_dosage": "200 mg/kg and 400 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:16.115441+00:00"}
{"study_id": 8830, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to analyze the neuroprotective effects of Celastrus paniculatus oil on chronic stress-induced cognitive deficits in rats.", "results_summary": "Celastrus paniculatus oil improved spatial learning and memory in stressed rats, as evidenced by better performance in RAM and T-maze tasks, and reduced anxiety-like behavior in EPM. The effects were statistically significant (P < 0.001).", "population_specificity": "Chronically stressed rats", "effective_dosage": "400 and 600 mg/kg, administered intraperitoneally once daily", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:16.687168+00:00"}
{"study_id": 8832, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the effects of Celastrus paniculatus extract on serum biochemistry, particularly trace element concentrations, in aging rats.", "results_summary": "The study found significant variations in trace element concentrations, including increased copper and cobalt levels in treated aged rats, while zinc content showed non-significant changes. Manganese levels in treated rats were higher than young controls but lower than age controls.", "population_specificity": "20-month-old albino rats, compared to 3-month, 12-month, and 20-month-old controls.", "effective_dosage": "2g/kg body weight, orally administered.", "study_duration": "16 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:16.796536+00:00"}
{"study_id": 8831, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify bioactive constituents of Celastrus paniculatus and evaluate its antiproliferative activity in MCF-7 breast cancer cells.", "results_summary": "The study isolated three new \u03b2-dihydroagarofuranoid sesquiterpenes, with the major constituent showing antiproliferative effects (IC50 of 17\u00b11\u03bcM) via apoptosis and autophagy. It also targeted key signaling effectors (Akt, NF-\u03baB, p53, MAP kinases) and increased reactive oxygen species production.", "population_specificity": "MCF-7 breast cancer cells (in vitro study).", "effective_dosage": "IC50 of 17\u00b11\u03bcM (concentration, not dosage).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:17.494714+00:00"}
{"study_id": 8833, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relaxing action of a methanolic extract from Celastrus paniculatus seeds on rat and human ileum to confirm its traditional use for intestinal spasms.", "results_summary": "CPE showed a potent inhibitory effect on rat and human ileum motility, with IC50 values of 0.24 and 0.26 \u00b5g/mL, respectively, and maximal relaxation effects near 99%. The effect was myogenic and dependent on L-type calcium channels.", "population_specificity": "Rat and human ileum tissues (in vitro study).", "effective_dosage": "0.0001-10 \u00b5g/mL (single exposure in vitro).", "study_duration": "Not specified (acute in vitro experiment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:18.094706+00:00"}
{"study_id": 8834, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the free-radical-scavenging capacity and neuroprotective effects of Celastrus paniculatus seed oil (CPO) and extracts (ME and EE) against oxidative stress and glutamate-induced toxicity in neuronal cells.", "results_summary": "CPO, ME, and EE demonstrated dose-dependent free-radical-scavenging and neuroprotective effects, with CPO being the most effective in attenuating H\u2082O\u2082- and glutamate-induced neuronal death. The extracts increased catalase activity and reduced MDA levels, suggesting antioxidant mechanisms, though CPO's superior neuroprotection may involve additional pathways beyond free-radical scavenging.", "population_specificity": "Embryonic rat forebrain neuronal cells (FBNC)", "effective_dosage": "Not specified (dose-dependent effects observed)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:20.284705+00:00"}
{"study_id": 8835, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the muscle-relaxing activity of Celastrus paniculatus seed extract and its fractions on rat intestine, and to identify bioactive compounds responsible for this effect.", "results_summary": "The study found that Celastrus paniculatus seed extract and its carbon tetrachloride fraction induced concentration-related relaxation of rat ileum, with three newly isolated sesquiterpene polyol esters showing relaxant effects at 1 microg/mL.", "population_specificity": "Rat intestine (in vitro)", "effective_dosage": "0.001 - 100 microg/mL (extract); 0.01 - 10,000 ng/mL (carbon tetrachloride fraction); 1 microg/mL (isolated metabolites)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:21.847025+00:00"}
{"study_id": 8836, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of water-soluble extracts of Celastrus paniculatus (CP-WSE) against glutamate-induced toxicity in neuronal cells.", "results_summary": "CP-WSE significantly attenuated glutamate-induced neuronal death and reversibly inhibited NMDA-activated whole-cell currents, suggesting neuroprotection via modulation of glutamate receptor function.", "population_specificity": "Enriched forebrain primary neuronal cell (FBNC) cultures from rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:23.608618+00:00"}
{"study_id": 8860, "supplement_id": 996, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of celery seed extract, containing 3-n-butylphthalide, on anxiety and depression in hypertensive patients.", "results_summary": "Celery seed extract significantly reduced anxiety and depression symptoms, as measured by BAI and BDI scores, and also improved blood pressure parameters in hypertensive patients.", "population_specificity": "Hypertensive patients", "effective_dosage": "1.34 g per day (4 capsules)", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:24.489288+00:00"}
{"study_id": 8838, "supplement_id": 995, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Celastrus paniculatus seed oil could reverse scopolamine-induced memory deficits and improve spatial memory in rats.", "results_summary": "Chronic treatment with CP seed oil reversed scopolamine-induced memory deficits in rats, while acute treatment did not. CP alone slightly improved maze performance on the first day but did not affect locomotor activity or brain acetylcholinesterase levels.", "population_specificity": "Young adult rats", "effective_dosage": "50, 200, or 400 mg/kg daily", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:25.338615+00:00"}
{"study_id": 8837, "supplement_id": 995, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidant and neuroprotective effects of aqueous extracts from Celastrus paniculatus seeds in vitro and in neuronal cell cultures.", "results_summary": "All three aqueous extracts (room temperature, hot water, and acid extracts) demonstrated dose-dependent free radical scavenging capacity and significantly attenuated H2O2-induced neuronal death, with the acid extract being the most effective. The extracts reduced lipid peroxidation and increased catalase activity, suggesting neuroprotective effects against oxidative stress.", "population_specificity": "Rats (in vivo antioxidant assays) and enriched forebrain primary neuronal cell cultures (in vitro neuroprotection assays).", "effective_dosage": "Not specified (dose-dependent effects observed but exact amounts not provided).", "study_duration": "Not specified (10-day FBNC cultures mentioned, but intervention duration unclear).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:27.546135+00:00"}
{"study_id": 8839, "supplement_id": 995, "safety_score": "30", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of Celastrus paniculatus oil on the testes and liver of adult rats, focusing on antifertility potential and liver toxicity.", "results_summary": "The study found that Celastrus paniculatus oil caused testicular damage (vacuolization, germ cell depletion, and spermatogenesis arrest) and reversible liver necrosis in rats. Liver lesions resolved 45 days post-treatment, indicating potential antifertility effects and hepatic recovery.", "population_specificity": "Adult rats", "effective_dosage": "0.2 ml intraperitoneally every other day", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:27.584542+00:00"}
{"study_id": 8861, "supplement_id": 996, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to establish a predictive model linking xanthine oxidase inhibitory effects of celery seed extract to its chemical composition using MNN-PCA.", "results_summary": "The study developed a stable and accurate MNN-PCA model for predicting xanthine oxidase inhibition by celery seed extract, with high coefficients of determination (0.9998 for training, 0.8124 for test sets) and low error metrics. The model can identify key compounds responsible for the inhibitory effect, applicable to other herbal medicines.", "population_specificity": "Not specified (in vitro or computational study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:28.228432+00:00"}
{"study_id": 8862, "supplement_id": 996, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-tumor effects of Celery seed extract (CSE) and its mechanisms regarding apoptosis in human gastric cancer BGC-823 cells.", "results_summary": "CSE demonstrated anti-proliferative effects on BGC-823 cells in a dose- and time-dependent manner, significantly increasing apoptosis and inducing S-phase cell cycle arrest. Key proteins like cyclin A, CDK2, and bcl-2 were down-regulated, while bax was up-regulated.", "population_specificity": "Human gastric cancer BGC-823 cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:28.974840+00:00"}
{"study_id": 8863, "supplement_id": 996, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the toxicological effects of an alcoholic celery seed extract (A-CSE) in rats to determine its safety for potential therapeutic use.", "results_summary": "The study found no toxicologically significant effects from A-CSE at doses up to 5,000 mg/kg per day, with minor changes in liver weight and serum parameters deemed non-significant. No adverse effects were observed, suggesting a high safety profile.", "population_specificity": "Adult male and female rats.", "effective_dosage": "0, 150, or 5,000 mg/kg per day.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:30.198801+00:00"}
{"study_id": 185167, "supplement_id": 996, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antihypertensive effects of celery seed extract as a supplement for managing hypertension.", "results_summary": "Celery seed extract significantly reduced systolic, diastolic, and mean arterial blood pressure, as well as pulse pressure, compared to placebo, with no significant side effects reported.", "population_specificity": "52 patients with hypertension.", "effective_dosage": "1.34 g per day (4 capsules).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:31.383899+00:00"}
{"study_id": 185168, "supplement_id": 996, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and potential benefits of celery seed extract in hypertensive patients, particularly its effects on blood pressure, blood sugar, lipid profile, and kidney/liver function.", "results_summary": "The study found that celery seed extract was safe and significantly reduced blood pressure, fasting blood sugar, and improved lipid profiles (lowering TC, TG, LDL, and increasing HDL). It also showed beneficial effects on kidney and liver function without adverse changes in blood cells or electrolytes.", "population_specificity": "Hypertensive patients (51 participants)", "effective_dosage": "1.34 g extract per day (divided into 4 capsules)", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:33.572656+00:00"}
{"study_id": 8679, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antioxidant potential of Centrophenoxine (CPH) against rotenone-induced oxidative stress in a Parkinson's disease model.", "results_summary": "CPH co-treatment attenuated rotenone-induced motor dysfunction, oxidative damage, dopamine depletion, and enhanced antioxidant enzyme activity in the midbrain region of rats. Histological analysis confirmed CPH's protective effects against neuronal damage.", "population_specificity": "Sprague-Dawley (SD) rats with rotenone-induced neurotoxicity.", "effective_dosage": "Not specified", "study_duration": "Chronic administration (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:33.810847+00:00"}
{"study_id": 8681, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Centrophenoxine's potential to mitigate aluminium-induced oxidative stress and neuronal degeneration in rats.", "results_summary": "Centrophenoxine significantly reduced lipid peroxidation and increased reduced glutathione levels in both cerebrum and cerebellum, while also improving histoarchitecture of cellular layers damaged by aluminium exposure.", "population_specificity": "Rats exposed to aluminium-induced oxidative stress.", "effective_dosage": "100 mg/kg body weight/day", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:35.430827+00:00"}
{"study_id": 8680, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether centrophenoxine could mitigate rotenone-induced motor dysfunction and oxidative stress in rats, potentially offering neuroprotective benefits.", "results_summary": "Centrophenoxine co-treatment significantly reduced motor dysfunction, restored dopamine levels, and decreased lipid peroxidation in rotenone-treated rats, suggesting antioxidant-mediated neuroprotection.", "population_specificity": "Male Sprague Dawley rats", "effective_dosage": "100 mg/kg intraperitoneally, daily", "study_duration": "35 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:36.842423+00:00"}
{"study_id": 8682, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of Centrophenoxine in mitigating cognitive and enzymatic impairments caused by aluminum toxicity in the brain.", "results_summary": "Centrophenoxine restored altered enzyme activities (Hexokinase, Succinate dehydrogenase, Mg\u00b2\u207a-dependent ATPase) in both cerebrum and cerebellum, though lactate dehydrogenase and acetylcholinesterase improvements were not significant in the cerebellum. It also improved short-term memory and cognitive performance impaired by aluminum exposure.", "population_specificity": "Animal model (aluminum-exposed subjects)", "effective_dosage": "Not specified for Centrophenoxine", "study_duration": "Six weeks (aluminum exposure period; Centrophenoxine post-treatment duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:37.527746+00:00"}
{"study_id": 8684, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate centrophenoxine's potential in mitigating aluminium-induced neurotoxicity and oxidative damage in the brain.", "results_summary": "Centrophenoxine significantly elevated superoxide dismutase and catalase activities and reduced lipid peroxidation in brain regions affected by aluminium toxicity, demonstrating its protective effects against oxidative damage.", "population_specificity": "Female Sprague Dawley rats", "effective_dosage": "100 mg/kg body weight/day", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:37.736102+00:00"}
{"study_id": 8683, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether centrophenoxine could modulate glutathione status in different brain regions of female rats exposed to aluminum toxicity.", "results_summary": "Centrophenoxine significantly improved reduced glutathione levels and glutathione reductase activity in aluminum-exposed brain regions and also had a notable effect when administered alone.", "population_specificity": "Female rats", "effective_dosage": "100 mg/Kg body weight/day (intraperitoneal)", "study_duration": "Six weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:39.669094+00:00"}
{"study_id": 8685, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Centrophenoxine could reverse age-related declines in acetylcholinesterase activity in specific brain regions of rats.", "results_summary": "Centrophenoxine increased acetylcholinesterase activity in the hippocampus and brain stem of aged rats but not in the cerebellum, suggesting a potential role in reversing age-related cholinergic decline and improving cognitive and synaptic functions.", "population_specificity": "Aged rats (4, 8, 16, and 24 months old)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:39.680553+00:00"}
{"study_id": 8686, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of Centrophenoxine on catecholamine response and postural blood pressure in patients with orthostatic hypotension due to brainstem ischemia.", "results_summary": "Centrophenoxine treatment (800 mg daily for 10 days) normalized catecholamine responses to posture (increased norepinephrine and reduced epinephrine excretion) and reduced orthostatic blood pressure fall, though clinical effects did not significantly correlate with restored catecholamine response.", "population_specificity": "25 patients with orthostatic hypotension due to brainstem ischemia.", "effective_dosage": "800 mg daily", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:41.987528+00:00"}
{"study_id": 8687, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of Centrophenoxine (CPH) on body composition parameters and cognitive performance in elderly individuals with medium-level dementia.", "results_summary": "The study found that CPH treatment led to better performance in psychometric tests and a significant increase in intracellular water content (2.2-2.5% by weight), suggesting rehydration of intracellular mass, consistent with CPH's free radical scavenger properties.", "population_specificity": "50 elderly individuals (25 men, 25 women, average age 77) with medium-level dementia residing in an old age home.", "effective_dosage": "2 g/day (divided into 2x2 tablets of Helfergin(500)).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:43.167562+00:00"}
{"study_id": 8688, "supplement_id": 997, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of Centrophenoxine (CPH) in improving memory functions in elderly patients with medium-level dementia.", "results_summary": "CPH treatment showed improvement in memory functions for 48% of the treatment group compared to 28% in the placebo group, suggesting potential benefits for dementia patients. The study also noted CPH as a useful and harmless drug for treatment and possibly prevention of dementia.", "population_specificity": "50 elderly individuals (25 men, 25 women) over 60 years old (average age 77) with medium-level dementia, residing in an old age home.", "effective_dosage": "2 g/day (2 x 2 tablets of Helfergin500, 500 mg each).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:45.105968+00:00"}
{"study_id": 8689, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of Centrophenoxine (CPH) on the lateral diffusion coefficient of proteins (D) in hepatocyte membranes and its potential to counteract age-related changes in old rats.", "results_summary": "CPH increased the lateral diffusion coefficient (D) in old rats but had no effect in young rats. BCE-001, a comparator drug, was more effective than CPH in improving D and retarding age-related weight loss in old rats.", "population_specificity": "Male rats (young: 2.7 months; old: 24-26 months)", "effective_dosage": "Not specified", "study_duration": "26 to 42 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:45.745701+00:00"}
{"study_id": 8691, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Centrophenoxine could reverse age-related increases in protein cross-linking in brain synaptosomes of rats.", "results_summary": "Centrophenoxine treatment for 2 months reversed age-related shifts toward higher molecular weight proteins in old rats, suggesting a reduction in oxidative damage and supporting its potential anti-aging effects.", "population_specificity": "2-, 12-, and 24-month-old CFY female rats", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:46.618840+00:00"}
{"study_id": 8690, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Centrophenoxine could reduce lipofuscin accumulation in the retinal pigment epithelium (RPE) of aged rhesus monkeys.", "results_summary": "The study found no statistically significant difference in lipofuscin granule fraction or size between Centrophenoxine-treated and control groups, indicating no measurable effect under the tested conditions.", "population_specificity": "Aged rhesus monkeys (~20 years old)", "effective_dosage": "80 mg/kg (IM injection, daily)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:47.109586+00:00"}
{"study_id": 8692, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the influence of centrophenoxine treatment on beta-adrenoceptor density in the brain cortex of old mice.", "results_summary": "Centrophenoxine treatment for 40 days resulted in a statistically significant increase in beta-adrenoceptor density in old mice, while a 5-day treatment showed only a non-significant increasing trend. Receptor affinity remained unchanged across all groups.", "population_specificity": "21-month-old mice", "effective_dosage": "3.8 mg/day, intraperitoneal injection", "study_duration": "5 days and 40 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:48.335524+00:00"}
{"study_id": 8693, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of Centrophenoxine on senile Purkinje neurons in rats, focusing on cytochemical changes and nucleocytoplasmic interactions.", "results_summary": "Centrophenoxine treatment led to nucleolar hyperactivity, regeneration of Nissl patches, increased alpha-esterase activity, and decreased acid phosphatase and simple esterase activity in senile Purkinje cells. The drug appeared to revitalize nucleocytoplasmic interactions and regenerate general cytoplasm.", "population_specificity": "Senile white rats", "effective_dosage": "100 mg/Kg body weight/day", "study_duration": "60 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:48.468997+00:00"}
{"study_id": 8694, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Centrophenoxine could reverse age-related declines in RNA synthesis rates in the brain cortex of rats.", "results_summary": "The study found that old rats (26 months) showed a significant decrease in RNA synthesis rates compared to younger groups, but Centrophenoxine treatment restored these rates nearly to adult levels. The results suggest Centrophenoxine may counteract age-related declines in RNA synthesis, possibly via free-radical scavenging.", "population_specificity": "Female CFY rats (young: 1.5 months, adult: 13 months, old: 26 months)", "effective_dosage": "100 mg per kg body weight per day", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:51.061734+00:00"}
{"study_id": 8695, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Centrophenoxine reduces lipofuscin accumulation in the retinal pigment epithelium (RPE) and frontal cortex of senescent rats.", "results_summary": "Centrophenoxine treatment did not reduce lipofuscin content or alter the ultrastructure of lipofuscin granules in the RPE or frontal cortex, despite significant age-related increases in lipofuscin in control animals.", "population_specificity": "Senescent female Fischer rats (106 weeks old at study start).", "effective_dosage": "80 to 120 mg/kg body weight, daily.", "study_duration": "11 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:51.779044+00:00"}
{"study_id": 8696, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Centrophenoxine could reverse age-related increases in membrane microviscosity and cholesterol content in synaptosomes.", "results_summary": "Centrophenoxine treatment (100 mg/kg daily for 2 months) reversed age-dependent increases in membrane microviscosity and cholesterol content in synaptosomes, restoring values nearly to adult levels. The results support the membrane hypothesis of aging, linking free-radical damage to cellular aging.", "population_specificity": "Male CFY rats (young, adult, and old age groups: 2, 12, and 24 months old).", "effective_dosage": "100 mg/kg body weight daily.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:54.211113+00:00"}
{"study_id": 8701, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Centrophenoxine could slow lipofuscin accumulation and improve cell division capacity in human glia cells, potentially delaying cellular aging.", "results_summary": "Centrophenoxine treatment reduced lipofuscin accumulation and increased cell division capacity by 30\u201340% in human glia cells, suggesting a delay in cellular aging.", "population_specificity": "Diploid human glia cells in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:54.452669+00:00"}
{"study_id": 8697, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of Centrophenoxine (CPH) on age-dependent synaptic alterations in the cerebellar glomerulus of rats, comparing acute and chronic administration patterns.", "results_summary": "CPH treatment increased synaptic surface density (SV) in both acute and chronic administration. Chronic treatment slowed the decrease in numerical density (NV), while acute treatment increased synaptic junction length (L) without significantly altering NV.", "population_specificity": "Female Wistar rats aged 3 to 28 months.", "effective_dosage": "100 mg CPH/kg body weight, injected intraperitoneally (daily for acute treatment, 3 times per week for chronic treatment).", "study_duration": "6 weeks (acute), 5 months (chronic).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:55.136619+00:00"}
{"study_id": 8700, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Centrophenoxine (CPH) could reverse age-related synaptic deterioration in the cerebellar glomerulus of old rats.", "results_summary": "CPH treatment restored synaptic parameters (surface density and total length of synaptic contact zones) in old rats to levels observed in young and adult rats, while numerical synapse density remained unchanged. The results suggest CPH may stimulate neural metabolism in aging brains.", "population_specificity": "Female Wistar rats (3, 18, and 28 months old)", "effective_dosage": "100 mg/kg body weight, intraperitoneal injections", "study_duration": "40 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:56.084327+00:00"}
{"study_id": 8703, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Centrophenoxine could prevent lipofuscin formation in young mice if administered before pigmentogenesis onset.", "results_summary": "Centrophenoxine did not stop lipofuscin formation in 1-month-old mice but consistently reduced pigment levels in neurons of the cerebral cortex and hippocampus compared to controls. The reduction was duration-dependent, with significant effects observed after five or more months of treatment.", "population_specificity": "1-month-old mice", "effective_dosage": "Not specified", "study_duration": "Five months or more", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:56.575686+00:00"}
{"study_id": 8702, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of Centrophenoxine on monovalent electrolyte contents (potassium, sodium, and chloride) in brain cortical cells of old female Wistar rats.", "results_summary": "Centrophenoxine decreased potassium content in both nucleus and cytoplasm without altering sodium levels, leading to a significant increase in the Na+/K+ ratio. A slight decrease in chloride content was observed in nuclei, and the results suggest potential rehydration effects that may restore ionic strength to levels seen in young adult animals.", "population_specificity": "Old female Wistar rats", "effective_dosage": "100 mg/kg body weight, intraperitoneal injection", "study_duration": "20 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:57.174950+00:00"}
{"study_id": 8704, "supplement_id": 997, "safety_score": "70", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to determine whether Centrophenoxine could effectively counteract acute diazepam intoxication in rats and mice.", "results_summary": "Centrophenoxine significantly improved survival and recovery rates in both rats and mice compared to untreated controls, with treated rats showing full recovery and treated mice exhibiting rapid disappearance of intoxication signs.", "population_specificity": "20 white rats (150 gm) and 40 white mice (20 gm), equal numbers of both sexes.", "effective_dosage": "50 mg/body weight (single dose for rats, repeated after two hours for mice).", "study_duration": "Acute intervention (effects observed within hours).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:15:59.800730+00:00"}
{"study_id": 8705, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to determine whether Centrophenoxine could effectively counteract acute poisoning from chlordiazepoxide in rats.", "results_summary": "Centrophenoxine administration (50 mg/kg) reversed signs of intoxication within 24 hours, while untreated controls experienced worsening symptoms and some fatalities. The results support Centrophenoxine's potential efficacy in treating chlordiazepoxide poisoning.", "population_specificity": "20 white male rats (150 gm body weight)", "effective_dosage": "50 mg/kg of body weight (single dose)", "study_duration": "24-hour observation post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:00.264088+00:00"}
{"study_id": 50704, "supplement_id": 997, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of cell membrane aging and evaluate Centrophenoxine as an anti-aging intervention based on the membrane hypothesis of aging (MHA).", "results_summary": "The study suggests Centrophenoxine as a potential anti-aging treatment targeting cell membrane aging, though detailed efficacy results are not provided. The abstract also mentions the emerging use of recombinant human growth hormone as another anti-aging method.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:02.120644+00:00"}
{"study_id": 8387, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of ceramides and sphingolipid metabolism in cardiovascular health, particularly how they are influenced by estrogen and differ between sexes.", "results_summary": "The study highlights that ceramides and sphingosine 1-phosphate play essential roles in cardiovascular physiology and are modulated differently in males and females, suggesting a link between estrogen activity and sphingolipid metabolism in cardiovascular disease outcomes.", "population_specificity": "Pre- and post-menopausal women, with comparisons to men.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:03.572851+00:00"}
{"study_id": 8386, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether FTY720, which mimics S1P bioactivity, could prevent memory impairments and modulate sphingolipid metabolism (including ceramides) in Alzheimer's disease models, particularly in APOE4 carriers.", "results_summary": "FTY720 prevented memory impairments in E4FAD mice by reducing toxic ceramide metabolites (d18:1/16:0 and d18:1/22:0), lowering amyloid-\u03b2 burden, and decreasing inflammation. Low plasma S1P levels were linked to memory test failures.", "population_specificity": "Transgenic mouse models of familial Alzheimer's disease carrying human APOE3 (E3FAD) or APOE4 (E4FAD).", "effective_dosage": "0.1 mg/kg and 0.5 mg/kg daily (oral gavage).", "study_duration": "15 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:03.926144+00:00"}
{"study_id": 8390, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of a body lotion containing ceramides on skin barrier properties, hydration, and the skin microbiome.", "results_summary": "The study found that the lotion improved skin barrier properties, increased levels of ceramides, cholesterol, and long-chain fatty acids, and positively altered the skin microbiome by increasing beneficial bacteria and enhancing functional potential.", "population_specificity": "Individuals with xerosis (dry skin)", "effective_dosage": "Not specified", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:04.509661+00:00"}
{"study_id": 8389, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of ceramide-based liquid crystal formulations (C1CH and C1CHCE) as topical treatments for psoriasis in mice.", "results_summary": "The ceramide-based formulations showed marked immunomodulatory effects, induced skin remodeling, and altered inflammatory biomarkers, but also increased some adverse skin changes like keratinization and vascular congestion.", "population_specificity": "Mice with imiquimod-induced psoriasis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:04.709720+00:00"}
{"study_id": 8388, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether ceramides and phosphatidylcholines in plasma and extracellular vesicles are associated with postoperative major adverse cardiovascular events (MACE) in patients undergoing carotid endarterectomy (CEA).", "results_summary": "Higher levels of specific ceramides and ceramide/PC ratios in LDL-EV and TEX-EV subfractions were significantly associated with an increased risk of MACE within three years post-CEA, suggesting their potential as biomarkers for identifying high-risk patients.", "population_specificity": "873 patients undergoing carotid endarterectomy from the Athero-Express biobank.", "effective_dosage": "Not specified", "study_duration": "Three-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:05.266867+00:00"}
{"study_id": 8392, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the mechanistic link between ceramide, cathepsin B, and GCase activity in Parkinson's disease pathogenesis.", "results_summary": "The study found that ceramide activates cathepsin B, which mediates prosaposin cleavage to form saposin C, a GCase coactivator. Disrupting ceramide production impaired this pathway, while increasing ceramide enhanced GCase activation.", "population_specificity": "Parkin-linked PD models (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:08.522267+00:00"}
{"study_id": 8391, "supplement_id": 998, "safety_score": "85", "efficacy_score": 90, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy of a ceramide-rich ointment in promoting wound healing and reducing pain in a patient with severe sacral sores.", "results_summary": "The ceramide-rich ointment led to a 50% reduction in wound diameter within 30 days, improved quality of life, reduced pain, and achieved 95% wound closure in 45 days without infections or adverse effects.", "population_specificity": "A 57-year-old male with hypertension, obesity, dyslipidemia, and coronary disease, post-coronary surgery.", "effective_dosage": "Not specified (gauzes embedded in ointment applied as part of treatment).", "study_duration": "45 days (30 days for initial response, 45 days for near-complete closure).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:09.153821+00:00"}
{"study_id": 8393, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of ceramides in the pathological mechanisms of cardiometabolic diseases and evaluate the latest ceramides-targeted therapies.", "results_summary": "The study found that ceramides play a detrimental role in cardiometabolic diseases such as cardiovascular disease, type II diabetes, and obesity, and highlighted the need for further research to develop targeted therapies.", "population_specificity": "Not specified (general review of clinical evidence).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:11.108053+00:00"}
{"study_id": 8394, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the relevance of nanocarriers as a safe and efficient delivery strategy for glucocorticoids and ceramides in treating skin disorders with barrier impairment.", "results_summary": "The abstract highlights that ceramides play a crucial role in skin barrier homeostasis and water-holding capacity, and their dysfunction is linked to skin diseases like atopic dermatitis and psoriasis. The study suggests nanocarriers could improve the safety and efficacy of glucocorticoids and ceramides in topical treatments.", "population_specificity": "Individuals with skin disorders exhibiting barrier impairment, such as atopic dermatitis and psoriasis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:12.097623+00:00"}
{"study_id": 8395, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether large extracellular vesicles (lEVs) act as vehicles for ceramide transfer and induce diabetes-associated endothelial apoptosis.", "results_summary": "The study found that lEVs from hyperglycemic conditions significantly increased C16 ceramide levels, which induced apoptosis in recipient endothelial cells via caspase 3 activation, while small EVs (sEVs) showed no such effect. Inhibition of nSMase2 or treatment with GW4869 abrogated this effect.", "population_specificity": "Human coronary artery endothelial cells (HCAECs) and murine endothelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:12.558711+00:00"}
{"study_id": 8397, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the mechanistic link between ceramides and downstream signaling in plant defense and development.", "results_summary": "The study found that ceramide accumulation in the acer acd5 mutant led to programmed cell death and activation of SA and ROS signaling pathways, demonstrating ceramides' essential role in plant defense. Overexpressing NahG suppressed cell death and ceramide accumulation, while BTH treatment restored the phenotype.", "population_specificity": "Arabidopsis thaliana (plants)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:12.927673+00:00"}
{"study_id": 8398, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether periplocymarin could mitigate doxorubicin-induced cardiotoxicity by modulating ceramide metabolism.", "results_summary": "Periplocymarin improved cardiac function, reduced cardiomyocyte apoptosis, and reversed doxorubicin-induced ceramide accumulation in serum, suggesting ceramide metabolism plays a role in its protective effects.", "population_specificity": "C57BL/6 mice and H9c2 cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:13.171572+00:00"}
{"study_id": 8396, "supplement_id": 998, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore whether disturbed glycolipid metabolism, particularly ceramides, is involved in the pathophysiology of encephalo-myelo-radiculo-neuropathy (EMRN) and to identify potential therapeutic targets.", "results_summary": "The study found significant accumulation of ceramides in cerebrospinal fluid from EMRN patients, along with upregulated C5 complement levels and anti-neutral glycolipid antibodies, suggesting dysregulated glycolipid metabolism and abnormal immune responses in this disorder.", "population_specificity": "Patients with encephalo-myelo-radiculo-neuropathy (EMRN).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:16:14.276673+00:00"}
